Wet Lab
December
Experiment team member recruitment
2024.12.14-2024.12.22

Upon the completion of our recruitment process, we are proud to introduce our group members: Wet Lab Group: Yuetong Ge, Qiyu Tan, Yueting Guo, Ziyan Qin, Qiuyan Wang, Mingcong Li, Hepeng Wang.

January
The team's first general meeting
2025.1.4

At our first general meeting, all members met each other for the first time. Led by our PI and team leader, we introduced ourselves and clarified the upcoming tasks.

Figure 1: Meeting on 1.4, we got to know each other and confirmed what to do next.
Sharing of Gold Medal Cases in Previous Years
2025.1.4-2025.1.27

We had 3 meetings online in total. Each member of the experiment group share one gold medal project which they thought was a example of a good iGEM project,and analysed the advantages and highlights of the project. In this process, we’d come to learn what is a good iGEM project.

February
Brainstorms of the project
2025.2.9-2025.2.14

Since we decided to develop a breast cancer detecting project, we began searching for available methods that could make our project possible and then looking for more papers on breast cancer to improve our understanding of the disease.

Collaborative interviews
2025.2.15-2025.2.22

During this period, we conducted extensive research with the HP team to understand the needs and perspectives of both the general public and medical professionals regarding breast cancer detection. This led us to design a breast cancer recurrence monitoring system capable of maintaining long-term functionality in vivo while providing detectable readouts ex vivo.

Background research
2025.2.15-2025.2.22

We found studies in the literature on the related properties of cancer-associated adipocytes (CAAs), which suggested that adipocytes have a function in response to changes in their surrounding breast cancer and may serve as a chassis for detection systems. We began an extensive literature search to understand the relationship between CAA and breast cancer. We also collect different sensing technology that can may be compatible with our objectives and communicate with model group to try to find the targets.

Collaborative interviews
2025.2.23-2025.2.28

To investigate whether adipocytes could serve as our engineering chassis cells, we collaborated with the HP group to conduct interviews with surgeons. These interviews focused on the application of autologous fat grafting technology in post-mastectomy reconstruction and breast augmentation surgeries. The positive feedback from our collaborative interviews with the HP group, which explored the clinical use of adipocytes in procedures like breast reconstruction, confirmed their suitability. This confirmation led us to finally select adipocytes as our engineering chassis cells and proceed with the investigation into biomarkers and output signals.

Background research
2025.2.23-2025.2.28

Our investigation into Cancer-Associated Adipocytes (CAAs) revealed that the transformation from normal adipocytes to CAAs involves the specific upregulation of multiple genes. During our survey of reporter genes, we identified two potential methods for ex vivo signal output: Gaussia Luciferase (Gluc) and melanin. Based on these findings, we began searching for a detection tool capable of sensing the upregulation of endogenous mammalian genes and featuring an editable signal output module.

March
Collaborative interviews
2025.3.1-2025.3.10

Following discussions with the HP group, we finalized Gluc as the output method for our detection system and, acting on interviewees' recommendations, initiated extensive literature research to preliminarily identify target genes that are specifically upregulated in response to factors secreted by breast cancer cells.

During this phase, we have selected four candidate target genes: PLOD2 (upregulated by PAI-1), LIF (upregulated by CXCLs), Fam3c (upregulated by TGF-β), and IL-6 (upregulated by IL-1β).

Find suitable detection system
2025.3.1-2025.3.10

Through literature research, we have identified three detection techniques suitable for our project.We selected RADAR (adenosine deaminase based programmable RNA sensor technology), CASP sensor (RNA sensing technology based on CASP high sensitivity to detect single point mutations) and PAS aptamer (aptamer based detection technology for small molecule proteins) to achieve the detection of high-expressed genes in CAAs.

Find the best group of target gene
2025.3.11-2025.3.30

Collaborative interviews with the HP group highlighted accuracy as the most critical factor in diagnostic projects. Consequently, we decided to adopt the RADAR technology-capable of simultaneous multi-gene detection-as our core methodology to achieve precise breast cancer detection. Building on this foundation, we partnered with the Modeling team to conduct screening analyses of different gene combinations, ultimately identifying PLOD2 and LIF as our target genes for detection.

Design of experiments at the stage of proof of concept
2025.3.11-2025.3.30

Upon finalizing the RADAR system as the core of our project, we conducted a thorough literature review and, based on the references, completed the experimental design for the proof-of-concept phase along with the construction of plasmid maps. Accordingly, we have compiled a comprehensive list of required experimental materials.

Finalized the project
2025.3.11-2025.3.30

We have reviewed our overall progress at this stage and improved the general introduction about the project and clarified the background, solution and application scenarios of the project.

April
Materials purchase
2025.4.1-2025.4.20

Under the guidance of our PI, we have already completed the plan of the proof-of-concept experiment. With the help of our instructor, we purchase the respective meterials in our proof-of-concept experiment plan.

Design the further experiment plan
2025.4.1-2025.4.20

Different students in the wet lab group were responsible for different parts. Yuetong Ge and Hepeng Wang carried out the design of RADAR. Qiyu Tan organized all of the parts we were going to use. Qiuyan Wang carried out the design of cell viability detection. Ziyan Qin finished the design of Gluc production as the output part. Mingcong Li and Yueting Guo carried out the design of verifying the target genes of adipocytes up-regulated by breast cancer secreted cytokines.

Figure 1: Team members shared their ideas on the group meeting
Materials purchase
2025.4.20-2025.4.30

We listed and purchased the required experimental materials according to the designed experimental plan.

Laboratory Safety Training
2025.4.20-2025.4.30

All members of experiment group traind together on laboratory safety.

May

Plasmid preparation

2025.05.12 - 2025.05.17

Event 1: Transformation: plasmid 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9→DH5α
Event 1: Transformation: plasmid 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9→DH5α
Plasmids

For ease of recording, we numbered our plasmids according to the following table.

Result 2

This week we transformed plasmids 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 into DH5α.

Procedures
  1. Prepare LB liquid medium according to the protocol: LB liquid medium
  2. Dilute the Ampicillin (Amp) to the final concentration of 100mg/ml
  3. Pour LB agar plates with 0.1mg/mL Amp
  4. Dissolve 4μg plasmids in 20μL ddH2O
  5. The transformation process follows protocol: Bacterial Transformation. We used 3μL of plasmid.
  6. Spread 150 μL competent cells without transformation on the plates (Amp+) as negative control.
  7. Pick single colonies from plates and culture in 5ml LB liquid medium with shaking at 220rpm for 6h.
  8. Store the transformed DH5α in a system of 200 μL glycerin and 800 μL bacteria solution.
Results
Result 1
Result 2
Result 3
Discussions
  • Untransformed DH5α couldn’t grow on the plates with Amp, which proves the effectiveness of antibiotic.
  • Transformed bacteria grew well.
  • Transformation is considered successful.
Event 2: Isolation: plasmid 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8 and 1.9
Event 2: Isolation: plasmid 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8 and 1.9
Plasmids

This week we isolated plasmids 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 and 3.1.

Procedures
  1. Expand culture: Remove 1ml transformed DH5α solution into 200ml LB liquid medium with Amp, and shake at 220 rpm for 7h.
  2. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
  3. Test the plasmid concentration by nano100.
Results
Result 3
Discussions
  • The concentration of plasmid 1.1 is higher then expected, we plan to perform electrophoresis to verify if the plasmids we extracted are correct.

2025.05.19 - 2025.05.24

Event 1: Digestion and agarose gel electrophoresis: plasmid 1.3, 1.4, 1.6, 1.7, 1.8, 1.9, 1.1, 1.2, 1.5
Event 1: Digestion and agarose gel electrophoresis: plasmid 1.3, 1.4, 1.6, 1.7, 1.8, 1.9, 1.1, 1.2, 1.5

We digested plasmid 1.1-1.9 and performed agarose gel electrophoresis twice to verify that the plasmids were successfully transformed and isolated.

Round 1: Tested plasmid 1.3, 1.4, 1.6, 1.7, 1.8, 1.9

Round 2: Tested plasmid 1.1, 1.2, 1.5

In Round 1 we noticed some of the plasmids' concentration were lower than we expected, so we configured 2 systems in Round 2 to ensure the concentration of our plasmids.

Procedures
  1. We perform digestion according to the protocol: Restriction Digest of Plasmid DNA. The digestion systems are listed below: (the arrows in the "Plasmid Concentration" column indicate dilution, for example, 8200→600 means dilute the plasmids from 8200ng/μL to 600ng/μL)
  2. Result 2

    Table1: Digestion system of Round 1 (plasmid 1.3, 1.4, 1.6, 1.7, 1.8, 1.9)

    Result 2

    Table2: Digestion system of Round 2 (plasmid 1.1, 1.2, 1.5)

  3. We perform agarose gel electrophoresis following the protocol: Agarose gel electrophoresis (DNA)
    In Round 1 the concentration of agarose is 0.83%. In Round 2 the concentration of agarose is 1%.
    4μL 6x loading buffer was added into every 20μL sample.
    Run the gel at 135V for 40min.
Results
Result 1
Result 1

Figure 1: Profile of Round 1 (DNA mass 600ng)

Result 2
Result 2

Figure 2: Profile of Round 2 (DNA mass 600ng)

Discussions
  • Round 1:
    The results of round 1 are basically correct. There could be something wrong with the gel, making the marker not straight enough.
  • Round 2:
    The bands of p1.1 are correct and the concentration seems to be right.
    There wasn’t any band of p1.2 on the gel, so we plan to extract p1.2 one more time.
    Some of the bands of p1.5 are correct, but there were indeterminate bands,so p1.5 needs to be further verified.
Event 2: Transformation: plasmid 3.1→DH5α
Event 2: Transformation: plasmid 3.1→DH5α

This week we transformed plasmids 3.1 into DH5α.

Procedures
  1. Procedures were the same as described in week1
Results
Result 3
Discussions
  • Untransformed DH5α couldn’t grow on the plates (Amp+), which proves the effectiveness of ampicillin.
  • Transformed bacteria grew well.
Event 3: Isolation: plasmid 1.2, 1.5, 3.1
Event 3: Isolation: plasmid 1.2, 1.5, 3.1

This week we isolated plasmid 1.2, 1.5, 3.1 in DH5α.

Procedures
  1. Procedures were the same as described in week1
Results
Result 3
Discussions
  • All the plasmids seem to be extracted successfully and need further verification.
June

2025.06.02

Event 1: Digestion and agarose gel electrophoresis: plasmid 1.2, 1.5, 3.1
Event 1: Digestion and agarose gel electrophoresis: plasmid 1.2, 1.5, 3.1

We performed agarose gel electrophoresis to confirm that the previous operations on plasmid 1.2, 1.5, 3.1 were successful.

Procedures
  1. We perform digestion according to the protocol: Restriction digestion. The restriction digestion systems are as follows:
  2. (The arrows in the "Plasmid Concentration" column indicate dilution, for example, 8200→600 means dilute the plasmids from 8200ng/μL to 600ng/μL)

    Digestion system table

    Table1: Digestion system of plasmid 1.2, 1.5, 3.1

  3. We perform agarose gel electrophoresis following the protocol: Agarose gel electrophoresis.
    The concentration of the agarose gel is 1%.
    4μL 6x loading buffer is added in 20μL sample.
    Run the gel at 135V for 45min.
Results
Electrophoresis result

Figure 2: Profile of digestion (DNA mass 600ng)

Electrophoresis result
Discussions
  • The bands of plasmid 1.2 are correct, available to perform subsequent experiments.
  • Plasmid 1.5, 3.1 have unspecific bands, which indicates that these two plasmids may contain impurities.
July

Plasmid preparation

2025.07.01-2025.07.07

Event 1: Digestion and agarose gel electrophoresis: plasmid 1.1, 1.3, 1.6, 1.9
Digestion and agarose gel electrophoresis: plasmid 1.1, 1.3, 1.6, 1.9

We digested the plasmids and performed agarose gel electrophoresis in 3 rounds, respectfully on 05/July, 06/July and 07/July.

  • Round 1: Tested plasmid 1.1, 1.6
  • Round 2: Tested plasmid 1.1, 1.3, 1.6, 1.9
  • Round 3: Tested plasmid 1.1, 1.3, 1.6, 1.9
  • Procedures
    1. We perform digestion according to the protocol: Restriction Digest. The digestion systems are listed below: (the arrows in the "Plasmid Concentration" column indicate dilution, for example, 8200→600 means dilute the plasmids from 8200ng/μL to 600ng/μL)

      Table1: Digestion system of Round 1(plasmid 1.1, 1.6)

      Table2: Digestion system of Round 2(plasmid 1.1, 1.3, 1.6, 1.9)

      Table3: Digestion system of Round 3(plasmid 1.1, 1.3, 1.6, 1.9)

      (1) Digest under 37°C for 2h.
      (2) Each systems contain 600ng plasmids.
      (3) All systems are supplemented with ddH2O to 20μL.
    Results
    Result 3
    Result 3
    Result 3

    Figure 1: Profile of round 1

    Figure 2: Profile of round 2

    Figure 3: Profile of round 3

    Discussions
    • Round 1:
      We suspect that the loss of plasmid during the digestion may be the reason why bands 1.1, 1.6 are not visible.
    • Round 2:
      The electrophoresis results for samples 1.3, 1.6, and 1.9 are clear and correct. For sample 1.1, we suspect that concentration of 1.1 is too low.

    2025.07.08-2025.07.14

    Event 1: Isolation: plasmid 1.2, 1.4, 1.8, 1.9
    Event 1: Isolation: plasmid 1.2, 1.4, 1.8, 1.9

    We cultured bacteria and used maxiprep kit to extract more.

    Procedures
    1. Added 900μL bacteria solution stored with glycerin to 200mL LB liquid medium (Amp+) and 100μL to 5mL LB liquid medium (Amp+), shake both at 220rpm for 8h. After centrifugation at 8000rpm for 5 min, we harvested the bacteria precipitate.
    2. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    3. Test the plasmid concentration by nano100.
    Results
    Plasmid concentration result
    Event 2: Repeat isolation: plasmid 1.2, 1.4
    Event 2: Repeat isolation: plasmid 1.2, 1.4

    We extracted plasmid 1.2, 1.4 for a second time.

    Procedures
    1. Add 900μL stored bacteria solution to 200mL LB (Amp+) and 100ul bacteria solution to 5mL LB (Amp+), then shake at 220rpm, 37°C overnight.
    2. Centrifuge at 8000rpm for 5 min.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.
    Results
    Plasmid concentration result
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.1, 3.1, 1.8, 1.9, 1.4
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.1, 3.1, 1.8, 1.9, 1.4

    We digested the plasmids and performed agarose gel electrophoresis twice.

  • Round 1: Tested plasmid 1.1, 3.1, 1.8, 1.9
  • Round 2: Tested plasmid 1.4
  • Procedures
    1. We perform digestion according to the protocol: Restriction Digestion. The digestion systems are listed below:
      Digestion system table

      Table1: Digestion system of Round 1 (plasmid 1.1, 3.1, 1.8, 1.9)

      Digestion system table

      Table2: Digestion system of Round 2 (plasmid 1.4)

      Digest 600ng plasmids in 20μL system at room temperature overnight.
    2. We perform agarose gel electrophoresis following the protocol: Agarose Gel Electrophoresis.
      Concentration of the gel is 1%.
      Run the gel at 135V for 40min.
    Results
    Result 1

    Figure 1: Profile of Round 1 (DNA mass 600ng)

    Result 2

    Figure 2: Profile of Round 2 (DNA mass 600ng)

    Result 1
    Result 2

    2025.07.15-2025.07.21

    Event 1: Transformation: plasmid 1.2→DH5α
    Event 1: Transformation: plasmid 1.2→DH5α

    This week we transformed plasmid 1.2 into DH5α.

    Procedures
    1. Add 600ng plasmids (3μL) to 50μL competent cells.
    2. The transformation process follows protocol: Bacterial Transformation.
    3. After transformation, spread 150μL bacteria solution on one plate (Amp+) and 200μL on another.
    4. Spread 200μL competent cells without transformation as a control to test the effectiveness of Ampicillin.
    Event 2: Isolation: plasmid 1.2
    Event 2: Isolation: plasmid 1.2

    We extracted plasmid 1.2 for the third time.

    Procedures
    1. We picked 4 colonies (2 from each plates) and shake in 5mL LB liquid medium at 220rpm for 6.5h, then stored the bacteria solution with glycerin.
    2. We add 1mL bacteria solution from each tube (from 200μL plates) to 200mL LB liquid medium and shake at 220rpm overnight.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.
    Results
    • The concentration of plasmid 1.2 is 335ng/μL.
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.2
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.2

    We digested the plasmid 1.2 and performed agarose gel electrophoresis.

    Procedures
    1. Digest the plasmids at room temperature overnight according to the following system:
      Digestion system table

      Table1: Digestion system of plasmid 1.2

    2. We perform digestion according to the protocol: Restriction Digestion.
    3. We perform agarose gel electrophoresis following the protocol: Agarose Gel Electrophoresis.
      Concentration of the gel is 1%.
      Run the gel at 135V for 40min.
    Results
    Result

    Figure 1: Profile of digestion (DNA mass 600ng)

    Result

    2025.07.22-2025.07.28

    Event 1: Transformation: plasmid 1.10,1.11→DH5α
    Event 1: Transformation: plasmid 1.10,1.11→DH5α

    This week we transformed plasmid 1.10,1.11 into DH5α

    Procedures
    1. Add 600ng plasmids (3μL) to 50μL competent cells.
    2. The transformation process follows protocol: Bacterial Transformation.
    3. After transformation, spread 150μL bacteria solution on one plate (Amp+) and 200μL on another.
    4. Spread 200μL competent cells without transformation as a control to test the effectiveness of Ampicillin.
    Event 2: Isolation: plasmid 1.10, 1.11
    Event 2: Isolation: plasmid 1.10, 1.11

    We extracted plasmid 1.10,1.11 for the first time.

    Procedures
    1. We picked 4 colonies (2 from each plates) and shake in 5mL LB liquid medium at 220rpm for 6.5h, then stored the bacteria solution with glycerin.
    2. We add 1mL bacteria solution from each tube (from 200μL plates) to 200mL LB liquid medium and shake at 220rpm overnight.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.
    Results
    Plasmid concentration result
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.10, 1.11
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.10, 1.11

    We digested the plasmids 1.10,1.11 and performed agarose gel electrophoresis.

    Procedures
    1. Digest the plasmids at room temperature overnight according to the follow system:
      Digestion system table
    Results
    Result

    Figure 1: Profile of digestion (DNA mass 600 ng)

    Result

    Proof of concept in HEK293T

    2025.07.16-2025.07.21

    Event 1: Cell revival of HEK293T
    Event 1: Cell revival of HEK293T

    We revived HEK293T cells for future transfection experiments.

    Procedures
    1. We prepared complete DMEM medium following protocol: Complete DMEM Medium.
      (1)Remove 50 mL from a 500 mL bottle of DMEM medium and store it separately as serum-free medium.
      (2)Filter 50 mL FBS and 5 mL penicillin-streptomycin into the remaining 450 mL DMEM medium using a 0.22 μm filter membrane.
      (3)Mix well and store at 4°C.
    2. Retrieve HEK293T cells from liquid nitrogen storage.
    3. Thaw cells rapidly in a 37°C water bath, then immediately transfer to 5 mL complete DMEM medium and mix gently.
    4. Centrifuge at 1000 rpm, 4°C for 5 minutes, then discard the supernatant.
    5. Resuspend the pellet in 5 mL PBS using a pipette, then centrifuge again at 1000 rpm, 4°C for 5 minutes.
    6. Discard the supernatant and resuspend cells in 1 mL complete DMEM medium.
    7. Transfer the suspension into a 10 cm culture dish containing 9 mL complete DMEM and incubate overnight at 37°C with 5% CO2.
    Event 2: Cell passage of HEK293T
    Event 2: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. Take out the cells from incubator after culturing for 1 day since revival, aspirate the old culture medium, add 2 mL of PBS, and gently wash the cells.
    2. Discard the supernatant, add 1 mL of PBS and 1 mL of trypsin to the culture dish, and digest at room temperature for 1 minute.
    3. Discard the supernatant, return the old medium aspirated in step 1 to the culture dish, and resuspend the cells.
    4. Evenly transfer the cell suspension into one 15 mL tube, and centrifuge at 1000 rpm, 4°C for 5 minutes.
    5. Discard the supernatant, resuspend the cells in 5 mL of PBS, and centrifuge at 1000 rpm, 4°C for 5 minutes.
    6. Discard the supernatant, resuspend the cells in 1 mL of complete DMEM medium per tube, and evenly distribute the resulting cell suspension into three culture dishes pre-filled with 9 mL of complete DMEM medium.
    7. Incubate at 37°C with 5% CO2.
    Event 3: Cell seeding of HEK293T
    Event 3: Cell seeding of HEK293T

    We seed HEK293T cells in 24-well plates for subsequent transfection.

    Procedures
    1. Take out the culture dishes containing cells passaged at 1:3 ratio yesterday. Aspirate spent medium, wash with 2 mL PBS, then add 1 mL PBS and 1 mL trypsin for 1-minute digestion at 37°C.
    2. Adding back the original conditioned medium. Gently dissociate cells by pipetting.
    3. Transfer the cell suspension from all dishes to 15 mL tubes. Centrifuge at 1000xg, 4°C for 5 minutes.
    4. Aspirate supernatant, resuspend pellets in 5 mL PBS per tube, then centrifuge again at 1000xg, 4°C for 5 minutes.
    5. After final supernatant removal, resuspend each cell pellet in 1 mL complete DMEM medium.
    6. Take 200μl from one cell suspension tube and dilute in 24 mL complete DMEM. Dispense 500 μl aliquots into each well of two 24-well plates (total 48 wells).
    7. Incubate at 37°C with 5% CO2.
    8. We passage 1 dish of cells and preserve the residual cells in freezing medium (90% FBS + 10% DMSO).
    Event 4: Transfection: system1(plasmid 1.1, 1.2, 1.3, 1.8, 1.9)→HEK293T
    Event 4: Transfection: system1(plasmid 1.1, 1.2, 1.3, 1.8, 1.9)→HEK293T

    We transfected system1 (p1.1,1.2,1.3,1.8,1.9) to HEK293T cells and performed florescence imaging of EGFP and mCherry in transfected cells to explore the effectiveness of the RADAR system.

    Procedures
    1. We transfect plasmids into HEK293T cells as follows, Set up three replicate wells for each group:
      Digestion system table

      Table 1. List of transfection system

    2. Transfection procedures follow protocol: Cell transfection.
    3. Perform fluorescence imaging of EGFP and mCherry in post-transfectHEK293T cells.
    Results
    • All groups transfected with Sensor 1/Sensor 1-UGG showed strong red fluorescence, while the Sensor 1-UGG group also showed intense green fluorescence, confirming high transfection efficiency and proper functionality of mCherry and EGFP. However, transfection with Trigger 1 failed to induce EGFP expression in Sensor 1. We hypothesize that this may be due to endogenous TetR gene expression in the HEK293T cells, which could act on the TetO sequence preceding the Triggers and suppress Trigger expression. Alternatively, function of Sensor 1 might be weaker than anticipated, resulting in EGFP expression levels below the detection limit of fluorescence microscopy. Consequently, we plan to proceed with Sensor 2 and include tetracycline induction during transfection to determine the exact cause of the experimental failure.

    2025.07.22-2025.07.28

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.
    Event 2: Cell seeding of HEK293T
    Event 2: Cell seeding of HEK293T

    We seed HEK293T cells in 24-well plates for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3
      We seed one 24-well plate using 200μL cell resuspension.
    Event 3: Transfection: system2(plasmid 1.1, 1.4, 1.5, 1.8, 1.9)→HEK293T
    Event 3: Transfection: system2(plasmid 1.1, 1.4, 1.5, 1.8, 1.9)→HEK293T

    We transfected system2 (p1.1,1.4,1.5,1.8,1.9) to HEK293T cells and performed florescence imaging of EGFP and mCherry in transfected cells to explore the effectiveness of the RADAR system.

    Procedures
    1. We transfected plasmids into HEK293T cells according to the following systems below, and all treatments are performed in three replicate wells:
      Digestion system table

      Table 1. List of transfection system

    2. Prior to transfection, we replaced the old culture medium with fresh medium containing tetracycline.
    3. After transfection, we replace the medium on the following day. The concentration of tetracycline remains the same.
    4. Take photographs under 10× magnification in three different light conditions: mCherry excitation light, EGFP excitation light and brightfield (daylight).
    Results
    • The transfection results were similar to the previous experiment, as we still didn't observed Trigger-induced EGFP expression. Literature research revealed that this issue might be attributed to the high degradation rate of tetracycline. Consequently, we re-ordered doxycycline, which is more suitable for inducing the TetO system, and simultaneously performed amplification of Trigger plasmids (1.10, 1.11) lacking the TetO element.

    2025.07.29-2025.08.04

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.
    Event 2: Cell seeding: HEK293T
    Event 2: Cell seeding: HEK293T

    We seed HEK293T cells in two 24-well plates for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process in Week1.
      For 24 well plate, we add 100μL cell suspension to 6mL complete DMEM medium and add 500ul diluted cell suspension to each well,8 wells in total.
    2. We use the rest cells for passaging.
    Event 3: Transfection: plasmid 3.1→HEK293T
    Event 3: Transfection: plasmid 3.1→HEK293T

    We transfected HEK293T cells with plasmid 3.1 to express the Gaussia luciferase (Gluc).

    Procedures
    1. We transfect HEK293T cells with plasmid 3.1 as follows:
      Digestion system table
    2. Transfection procedures follow protocol: Cell transfection.
      (1)On the following 2 days, we collect the conditioned medium and replace with the fresh medium each day. The conditioned medium was collected in 1.5mL EP tube and centrifuge at 1000rpm for 5 minutes to get the supernatant.
      (2)The suprenatant was then stored at -80°C for further detection.
    Event 4: Culture medium collection and Gluc detection: plasmid 3.1→ HEK293T
    Event 4: Culture medium collection and Gluc detection: plasmid 3.1→ HEK293T
    Procedures
    1. Prepared the Gaussia-Lumi™ luciferase assay working solution by mixing the substrate with buffer at a 1:100 ratio.
    2. Add 100 μL of collected supernatant and 100 μL working solution to each well of the 96-well plate.
    3. Measure the chemiluminescence immediately using a microplate reader.
    4. Also, we use chemiluminescence imaging analysis system and cellphone to capture the luminescence images.
    Results
    Result

    Figure 1: Luminescence of culture supernatant from HEK293T cells collected at 24h, 48h and 72h after transfection.

    Result

    Figure 2: Analysis of sustained luminescence over 25 minutes between kinetics of luminescence production from Gluc.

    August

    Plasmid preparation

    2025.08.01-2025.08.07

    Event 1: Isolation: plasmid 1.6,1.7,1.10,1.11
    Event 1: Isolation: plasmid 1.6,1.7,1.10,1.11

    We extracted plasmid 1.6,1.7 for the first time and plasmind 1.10,1.11 for a second time.

    Procedures
    1. We picked 4 colonies (2 from each plates) and shake in 5mL LB liquid medium at 220rpm for 6.5h, then stored the bacteria solution with glycerin.
    2. We add 1mL bacteria solution from each tube (from 200μL plates) to 200mL LB liquid medium and shake at 220rpm overnight.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.

    The concentration of plasmid maxiprep are as follows:

    Plasmid concentration result
    Event 2: Digestion and agarose gel electrophoresis: plasmid 1.6,1.7,1.10,1.11
    Event 2: Digestion and agarose gel electrophoresis: plasmid 1.6,1.7,1.10,1.11

    We digested the plasmids and performed agarose gel electrophoresis in 2 rounds.
    Round 1: Tested plasmid 1.6,1.11
    Round 2: Tested plasmid 1.6,1.7,1.10

    Procedures
    1. We digest the plasmids at room temperature overnight according to the follow system:
      Digestion system table
      Digestion system table
    Results
    Result

    Figure 1: Profile of round1 (DNA mass 600 ng)

    Result

    Figure 2: Profile of round2 (DNA mass 600 ng)

    Result
    Result

    2025.08.08-2025.08.14

    Event 1: Digestion and agarose gel electrophoresis: plasmid 1.1,1.2,1.3,1.4,1.5,1.6,1.7,1.8,1.9,1.10,1.11,3.1
    Event 1: Digestion and agarose gel electrophoresis: plasmid 1.1,1.2,1.3,1.4,1.5,1.6,1.7,1.8,1.9,1.10,1.11,3.1

    We digested the plasmids and performed agarose gel electrophoresis in 3 rounds.
    Round 1: Tested plasmid 1.1,1.2,1.3,1.4
    Round 2: Tested plasmid 1.3,1.4,1.5,1.6,1.7,1.8,1.9,1.10
    Round 3: Tested plasmid 1.6,1.7,1.8,1.9,1.11,3.1

    Procedures
    1. We digest the plasmids at room temperature 1.5h according to the follow system:
      Digestion system table
      Digestion system table
      Digestion system table
    Results
    Result

    Figure 1: Profile of round1 (DNA mass 600 ng)

    Result

    Figure 2.1: Profile of round2 (DNA mass 600 ng)

    Result

    Figure 2.2: Profile of round2 (DNA mass 600 ng)

    Result

    Figure 3.1: Profile of round3 (DNA mass 600 ng)

    Result

    Figure 3.2: Profile of round3 (DNA mass 600 ng)

    Result
    Result
    Result
    Event 2: Transformation: plasmid 5.1→DH5α
    Event 2: Transformation: plasmid 5.1→DH5α

    This week we transformed plasmid 5.1 into DH5α

    Procedures
    1. Add 600ng plasmids (3μL) to 50μL competent cells.
    2. The transformation process follows protocol: Bacterial Transformation.
    3. After transformation, spread 150μL bacteria solution on one plate (Amp+) and 200μL on another.
    4. Spread 200μL competent cells without transformation as a control to test the effectiveness of Ampicillin.
    Event 3: Isolation: plasmid 5.1
    Event 3: Isolation: plasmid 5.1

    We extracted plasmid 5.1 for the first time.

    Procedures
    1. We picked 2 colonies ( from 150μL plate) and shake in 5mL LB liquid medium at 220rpm for 8h, then stored the bacteria solution with glycerin for 2 tubes.
    2. We add 1mL bacteria solution from each tube (from 200μL plates) to 200mL LB liquid medium and shake at 220rpm overnight.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.
    Results

    2025.08.15-2025.08.21

    Event 1: Transformation: plasmid 5.2,5.3,5.4→DH5α
    Event 1: Transformation: plasmid 5.2,5.3,5.4→DH5α

    This week we transformed plasmid 5.2,5.3,5.4 into DH5α

    Procedures
    1. Add 600ng plasmids (3μL) to 50μL competent cells.
    2. The transformation process follows protocol: Bacterial Transformation.
    3. After transformation, spread 150μL bacteria solution on one plate (Amp+) and 200μL on another.
    4. Spread 200μL competent cells without transformation as a control to test the effectiveness of Ampicillin.
    Event 2: Isolation: plasmid 1.10,1.11
    Event 2: Isolation: plasmid 1.10,1.11

    We extracted plasmind 1.10,1.11 for a third time.

    Procedures
    1. We add stored 1mL bacteria solution to 200mL LB liquid medium and shake at 220rpm overnight.
    2. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    3. Test the plasmid concentration by nano100.

    The concentration of plasmid maxiprep are as follows:

    Plasmid concentration result
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.6,1.7,1.10,1.11,3.1,5.1
    Event 3: Digestion and agarose gel electrophoresis: plasmid 1.6,1.7,1.10,1.11,3.1,5.1

    We digested the plasmids and performed agarose gel electrophoresis twice.
    Round 1: Tested plasmid 5.1,3.1
    Round 2: Tested plasmid1.10,1.11,5.1
    Round 3: Tested plasmid 1.6,1.7,1.10

    Procedures
    1. We digest the plasmids at room temperature overnight according to the follow system:
      Digestion system table
      Digestion system table
      Digestion system table
    Results
    Result

    Figure 1: Profile of round1 (DNA mass 600 ng)

    Result

    Figure 2: Profile of round2 (DNA mass 600 ng)

    Result

    Figure 3: Profile of round3 (DNA mass 600 ng)

    Digestion system table
    Digestion system table
    Digestion system table

    2025.08.22-2025.08.28

    Event 1: Isolation: 5.2, 5.3, 5.4
    Event 1: Isolation: 5.2, 5.3, 5.4
    Procedures
    1. We picked 4 colonies (2 from each plates) and shake in 5mL LB liquid medium at 220rpm for 6.5h, then stored the bacteria solution with glycerin.
    2. We add 1mL bacteria solution from each tube (from 200μL plates) to 200mL LB liquid medium and shake at 220rpm overnight.
    3. Isolate plasmids by Vigorous Maxiprep Kit following the protocol: Vigorous Plasmid Maxiprep.
    4. Test the plasmid concentration by nano100.
    Results

    The concentration of plasmid maxiprep are as follows:

    Plasmid concentration result
    Event 2: Digestion and agarose gel electrophoresis: plasmid 5.2, 5.3, 5.4
    Event 2: Digestion and agarose gel electrophoresis: plasmid 5.2, 5.3, 5.4

    We digest the plasmids at room temperature overnight according to the follow system:

    Procedures
    1. We digest the plasmids at room temperature overnight according to the follow system:
      Plasmid concentration result
    Results
    Plasmid concentration result

    Figure 1: Profile of digestion (DNA mass 600 ng)

    Plasmid concentration result

    Proof of concept in HEK293T

    2025.08.05-2025.08.11

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.
    Event 2: Cell seeding of HEK293T
    Event 2: Cell seeding of HEK293T

    We seed HEK293T cells in two 24-well plates for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3.
      We seed two 24-well plate using 200 μL cell suspension.
    Event 3: Transfection: System1 (plasmid 1.1,1.2,1.3,1.8,1.9,1.10,1.11) and system2 (plasmid 1.1,1.4,1.5,1.8,1.9,1.10,1.11) →HEK293T
    Event 3: Transfection: System1 (plasmid 1.1,1.2,1.3,1.8,1.9,1.10,1.11) and system2 (plasmid 1.1,1.4,1.5,1.8,1.9,1.10,1.11) →HEK293T

    We transfected system1 and system2 to HEK293T cells and performed florescence imaging of EGFP and mCherry in transfected cells to explore the effectiveness of the RADAR system.

    Procedures
    1. We transfect plasmids to HEK293T cells according to the following system
    2. For each system, 3 groups were set:
      (1) Two groups received plasmids lacking the Tet operator (p1.10 and p1.11), with one group induced using 100 ng/mL Doxycycline hyclate and the other serving as an uninduced control. (2) One group received plasmids containing the Tet operator (p1.8 and p1.9) and was induced with 100 ng/mL Doxycycline hyclate.
    3. The 24-well plate for system1:
      Plasmid concentration result

      Table 1. List of transfection system

    4. The 24-well plate for system2:
      Plasmid concentration result

      Table 2. List of transfection system

    Results

    As anticipated, EGFP expression was successfully triggered by their corresponding Triggers across all systems and treatment groups. This outcome not only validates the functionality of our RADAR system but also confirms the inducing effect of doxycycline. However, we observed that the untreated control groups (without doxycycline) showed the strongest signal, potentially due to cytotoxic effects caused by DMSO – the solvent used for doxycycline preparation – as illustrated below.

    Plasmid concentration result

    Figure 1: Images of HEK293T 48h after transfection.

    Event 4: Cell seeding of HEK293T
    Event 4: Cell seeding of HEK293T

    We seed HEK293T cells in two 24-well plates for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3.
      We seed 15 wells of one 24-well plate using 125 μL cell suspension.
    Event 5: Transfection: AND system→HEK293T
    Event 5: Transfection: AND system→HEK293T

    We transfected AND system to HEK293T cells and performed florescence imaging of EGFP and mCherry in transfected cells to explore the effectiveness of the RADAR system.
    Round 1: p1.1, p1.6, p1.7, p1.8, p1.9
    Round 2: p1.1, p1.6, p1.7, p1.10, p1.11

    Procedures
    1. We transfect plasmids to HEK293T cells as follows
    2. Round1
      Plasmid concentration result

      Table 1. List of transfection system

    3. Round2
      Plasmid concentration result

      Table 2. List of transfection system

    Results

    In Round 1, We found that when both Triggers were co-transfected, the induced EGFP expression was not significant. Combined with the results of Event 3, we speculate that this may be due to the TetO sequence still exerting a certain inhibitory effect on Trigger expression. Therefore, we decided to replace the plasmids with p1.10 and p1.11 and repeat the experiment.

    In Round 2, We observed that the EGFP expression induced by co-transfection with both Triggers was not significant. To rule out operational factors, we have decided to repeat the experiment.

    2025.08.12-2025.08.18

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.
    Event 2: Cell seeding of HEK293T
    Event 2: Cell seeding of HEK293T

    We seed HEK293T cells in one 24-well plate for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3.
      We seed one 24-well plate using 200 μL cell suspension.
    Event 3: Transfection of HEK293T
    Event 3: Transfection of HEK293T

    We stransfect the two systems as follows to verify the efficiency of RADAR system.

    Procedures
    1. We transfect plasmids to HEK293T cells in 6 wells according to the following system, each group for 2 wells:
      Plasmid concentration result

      Table 1. List of transfection system

    2. We transfect plasmids to HEK293T cells in 10 wells according to the following system, each group for 2 wells:
      Plasmid concentration result

      Table 2. List of transfection system

    Results

    For the transfection of Sensor 1-Gluc and other system, We observed that the luminescence intensity of the culture supernatant from cells co-transfected with Sensor 1-Gluc and Trigger 1 was significantly higher than that from cells transfected with Sensor 1 alone or with Sensor 1 and Trigger 2. This demonstrates that Gluc can function effectively as an output gene in the RADAR system.

    Plasmid concentration result

    Figure 1: Luminescence of HEK293T cells transfected with Sensor 1-Gluc and other plasmids.

    For the transfection of AND system, we found that co-transfection with both Trigger 1 and Trigger 2 can significantly induced EGFP expression, whereas individual Trigger transfection or the no-Trigger control group showed barely detectable EGFP. This result demonstrates that the system can simultaneously and specifically detect both Triggers.

    Plasmid concentration result

    Figure 2:Images of HEK293T 48h after transfection.

    Event 4: Cell seeding of HEK293T
    Event 4: Cell seeding of HEK293T

    We seed HEK293T cells in one 24-well plate for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3.
      We seed one 24-well plate using 200 μL cell suspension.

    2025.08.19-2025.08.25

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.

    2025.08.26-2025.09.03

    Event 1: Cell passage of HEK293T
    Event 1: Cell passage of HEK293T

    We passaged HEK293T cells for future transfection experiments.

    Procedures
    1. We routinely passaged HEK293T cells at a 1:3 ratio every other day to maintain cell viability for subsequent experiments.
    Event 2: Cell seeding of HEK293T
    Event 2: Cell seeding of HEK293T

    We seed HEK293T cells in one 24-well plate for subsequent transfection.

    Procedures
    1. Procedures were the same as the seeding process of July Week3.
      We seed two 24-well plates for transfection, one plate used 200μL cell suspension for 24 wells seeding, and one plate used 67μL for 8 wells seeding.
    Event 3: Transfection of HEK293T
    Event 3: Transfection of HEK293T

    We transfected plasmids to the cells to verify the efficiency of RADAR system

    Procedures
    1. We transfect plasmids to HEK293T cells in 8 wells according to the following system, each group for 2 wells:
      Plasmid concentration result

      Table 1. List of transfection system

    2. We transfect plasmids to HEK293T cells in 10 wells according to the following system, each group for 2 wells:
      Plasmid concentration result

      Table 2. List of transfection system

    3. We transfect plasmids to HEK293T cells in 6 wells of another plate according to the following system, each group for 2 wells:
      Plasmid concentration result

      Table 3. List of transfection system

    4. We collect the supernatant of conditioned medium at 12,24,36,48,60,72 hours post transfection
    Results

    The transfection results for Sensor 1-Gluc and its related plasmids were consistent with previous findings. Notably, the supernatant from cells transfected with the Sensor 1(PC)-Gluc plasmid (p5.2) exhibited exceptionally high Gluc expression, confirming the functionality of both the RADAR system and the positive control. Furthermore, the RADAR AND-gate sensor with Gluc as the output performed effectively, demonstrating high luminescence levels only upon co-transfection with both Trigger 1 and Trigger 2.

    Plasmid concentration result

    Figure 1:Luminescence of conditioned medium of HEK293T cells after transfection, Sensor 1+2-Gluc is a RADAR sensor with Gluc as the output, created by connecting Sensor 1 and Sensor 2 in tandem.

    We also collected culture supernatants at various time points from cells co-transfected with the AND Sensor-Gluc, Trigger 1, Trigger 2, and ADAR to investigate the kinetics of the RADAR system, the results are as follows:

    Plasmid concentration result

    Figure 2: Luminescence of conditioned medium from transfected HEK293T cells that were collected at indicated times.

    Validation in chassis-adipocytes

    2025.08.05-2025.08.11

    Event 1: Cell passaging: human preadipocytes
    Event 1: Cell passaging: human preadipocytes

    We passage the human preadipocytes to get more cells for experiments.

    Procedures
    1. The procedure of human preadipocytes passaging is similar to the HEK293T, the only difference was that the cells were maintained in 8 mL of specialized medium within a T25 flask.

    2025.08.12-2025.08.18

    Event 1: Medium changing: human preadipocytes
    Event 1: Medium changing: human preadipocytes

    We change the medium of human preadipocytes to keep the viability.

    Procedures
    1. We monitor cell morphology and medium color daily and perform medium changes accordingly to maintain cell viability.
    Event 2: Cell seeding of human preadipocytes
    Event 2: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 10 wells of two 6-well plates and 26 wells of two 24-well plates using cells in three T25 flask.
    2. We passage the rest cells into two T25 flasks.
    Event 3: Adipogenic Differentiation
    Event 3: Adipogenic Differentiation

    To obtain adipocytes for experiments, we subjected the preadipocytes to adipogenic differentiation.

    Procedures
    1. We change the medium in the two 24-well plates to adipogenic differentiation equipment to induce the preadipocytes to differentiate into adipocytes.
    2. From then on, we replaced the old adipogenic induction medium with fresh medium every 2 days and maintained this regimen for over 14 days to ensure continuous induction.
    Event 4: Cell seeding of human preadipocytes
    Event 4: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 10 wells of one 12-well plate using cells in one T25 flask.
    2. We passage the rest cells into two T25 flasks.

    2025.08.19-2025.08.25

    Event 1: Medium changing: human preadipocytes
    Event 1: Medium changing: human preadipocytes

    We change the medium of human preadipocytes to keep the viability.

    Procedures
    1. We monitor cell morphology and medium color daily and perform medium changes accordingly to maintain cell viability.
    Event 2: Adipogenic Differentiation
    Event 2: Adipogenic Differentiation

    To obtain adipocytes for experiments, we subjected the preadipocytes to adipogenic differentiation.

    Procedures
    1. We change the medium in the two 6-well plates (10 wells in total) and one 12-well plates (10 wells in total) to adipogenic differentiation equipment to induce the preadipocytes to differentiate into adipocytes.
    2. From then on, we replaced the old adipogenic induction medium with fresh medium every 2 days and maintained this regimen for over 14 days to ensure continuous induction.
    Event 3: Cell seeding of human preadipocytes
    Event 3: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 3 wells of one 6-well plate using cells in one T25 flask.
    2. We passage the rest cells into two T25 flasks.
    Event 4: Cell revival: human preadipocytes
    Event 4: Cell revival: human preadipocytes

    We revival the new human preadipocytes got from the company.

    Procedures
    1. We revival all of the cells in one T25 flask.
    2. Add 3ml fresh medium into the flask per 24h for 3 days.
    Event 5: Adipogenic Differentiation
    Event 5: Adipogenic Differentiation

    To obtain adipocytes for experiments, we subjected the preadipocytes to adipogenic differentiation.

    Procedures
    1. We change the medium in the one 6-well plates (3 wells in total) and to adipogenic differentiation equipment to induce the preadipocytes to differentiate into adipocytes.
    2. From then on, we replaced the old adipogenic induction medium with fresh medium every 2 days and maintained this regimen for over 14 days to ensure continuous induction.
    Event 6: Cell seeding of human preadipocytes
    Event 6: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 23 wells of one 24-well plate using cells in two T25 flasks.

    2025.08.26-2025.09.01

    Event1: Cell passaging: human preadipocytes
    Event1: Cell passaging: human preadipocytes

    We passage the human preadipocytes to get more cells for experiments.

    Procedures
    1. We have passaged the newly resuscitated human preadipocytes into two T25 flasks.
    Event2: Adipogenic Differentiation
    Event2: Adipogenic Differentiation

    To obtain adipocytes for experiments, we subjected the preadipocytes to adipogenic differentiation.

    Procedures
    1. We change the medium in the one 24-well plate (23 wells in total) and to adipogenic differentiation equipment to induce the preadipocytes to differentiate into adipocytes.
    2. From then on, we replaced the old adipogenic induction medium with fresh medium every 2 days and maintained this regimen for over 14 days to ensure continuous induction.
    Event3: Cell seeding of human preadipocytes
    Event3: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 20 wells of one 24-well plate and 2 wells of one 12-well plate using cells in one T25 flask.
    2. The rest cells are passaged in one T25 flask.
    Event4: Adipogenic Differentiation
    Event4: Adipogenic Differentiation

    To obtain adipocytes for experiments, we subjected the preadipocytes to adipogenic differentiation.

    Procedures
    1. We change the medium in the one 24-well plate (20 wells in total) and 12-well plate (2 wells in total) to adipogenic differentiation equipment to induce the preadipocytes to differentiate into adipocytes.
    2. From then on, we replaced the old adipogenic induction medium with fresh medium every 2 days and maintained this regimen for over 14 days to ensure continuous induction.
    September

    2025.09.02-2025.09.08

    Event 1: Oil red O staining
    Event 1: Oil red O staining

    We assessed the extent of adipocyte differentiation by Oil Red O staining.

    Procedures
    1. We use the cells in the two 6-well plates for Oil Red O staining.
    2. Prepare the Oil Red O working solution by mixing the Oil Red O stock solution with distilled water at a 3:2 ratio and thoroughly vortexing the mixture. Filter the solution through filter paper and collect the filtrate, which is the ready-to-use Oil Red O working solution.
    3. After completing the induction of differentiation, carefully aspirate the cell culture supernatant and wash the cells 1-2 times with 1×PBS. Add an appropriate amount of cell fixative and incubate at room temperature for 30 minutes for fixation.
    4. Upon completion of cell fixation, carefully aspirate the fixative solution and wash the cells twice with 1×PBS.
    5. Slowly add Oil Red O staining solution along the well wall, using 1mL per well, and incubate for 30 minutes at room temperature.
    6. After staining, remove the staining solution and rinse with PBS to eliminate non-specific staining.
    Results
    Plasmid concentration result

    Figure 1: Differentiated Adipocytes

    Event 2: rAAV infection
    Event 2: rAAV infection

    We used rAAV to deliver Sensor 1-Gluc, Trigger 1, and ADAR to validate the functionality of both the RADAR system and rAAV.

    Procedures
    1. Thaw viral stock on ice.
    2. repare infection mix.
    3. Add infection mix to cells, mix well.
    4. Incubate (37°C, 5% CO2) for 24h and change the medium.
    5. Using microscope to observe the mcherry.
    6. Round 1
      We infected the cells in the 24-well plates by rAAV carrying Sensor 1-Gluc first to explore the optimal viral dosage.
      We try to use 10μL, 15μL and 25μL virus per well to infect the cells.
    7. Round 2
      We infected the cells in the 24-well plates by 15μL rAAV carrying Sensor 1-Gluc and Trigger 1, with 5μL rAAV carrying ADAR, Using cells infected only with rAAV carrying Sensor 1-Gluc and ADAR as the control group, and non-infected cells as the blank group.
    Results

    Round 1
    Through observing expression of mcherry using the fluorescence microscope, we found that using 15μL can already achieved satisfactory infection efficiency, we decided to use 15 μL for all subsequent infections.

    Round 2
    Three days post-infection, the cell culture supernatant was collected and mixed with substrate for chemiluminescence detection. The results showed that co-infection with Trigger 1 induced a significant increase in luminescence from Sensor 1-Gluc, demonstrating that rAAV can effectively deliver the RADAR system and that the RADAR system functions robustly within adipocytes.

    Plasmid concentration result

    Figure 1:Luminescence of the conditioned medium from adipocytes infected by rAAVs carrying Sensor 1 and Trigger 1

    Event 3: Cytokine treatment
    Event 3: Cytokine treatment

    We treated the cells with cytokines to validate the upregulation of the target gene in adipocytes.

    Procedures
    1. Adipocytes in 12-well plates were treated with PAI-1, CXCL3, CXCL8, and a combination of PAI-1 and CXCL8, respectively, using untreated cells as a control.
    2. We use cytokines treat the cells for 48 hours.
    Event 4: qPCR
    Event 4: qPCR

    We quantified the expression of specific genes by qPCR.

    Procedures
    RNA extraction
    1. Remove the supernatant and wash the cells twice with PBS.
    2. Lyse the cells by adding a total of 500μL of Transzol up per group. Collect the cell lysate.
    3. Add infection mix to cells, mix well.
    4. Centrifuge the lysate at 12,000xg for 10 minutes at 4°C. After centrifugation, transfer the supernatant to a new tube.
    5. Add 100μL of chloroform per tube, vortex for 15 seconds, and then shake for 30 seconds until the mixture turns a uniform pink color.
    6. Incubate the mixture at room temperature for 5 minutes. And centrifuge the samples at 12,000xg for 15 minutes at 4°C.
    7. Carefully transfer the upper to a fresh tube.Precipitate the RNA by adding 250μL of isopropyl alcohol pertube. Incubate at room temperature for 10 minutes.
    8. Centrifuge at 12,000xg for 10 minutes at 4°C. Carefully discard the supernatant.
    9. Wash the RNA pellet by adding 500ul of 75% ethanol Vortex briefly to dislodge the pellet.
    10. Centrifuge at 7,500xg for 5 minutes at 4°C. Carefully aspirate the ethanol.
    11. Air-dry the pellet for approximately 10 minutes and dissolve the purified RNA in an appropriate volume of nuclease-free water. Measure the concentration.
    qPCR
    1. Prepare the reverse transcription mixture
    2. Use ddH2O to dilute 1000ng RNA extraction to 10μL
    3. Adding the mixture and the RNA to the Thermal Cycler. Set the system at 50°C for 5min and 80°C for 0.05min. Waiting for the system temperature until it decrease to 4°C.
    4. Adding 140μL ddH2O to the tube. And remove the reverse transcription product to the 96 well PCR plate (4μL each)
    5. Adding 5μL SYBR and 1μL primer, then seal the plate with a membrane.
    6. Centrifuge at 2250 rpm for 3 minutes. Put the plate into the Real-Time PCR Instrument.
    Results

    Treatment with either PAI-1 or CXCL8 specifically upregulated their respective target genes (PLOD2 and LIF), with CXCL8 inducing a more pronounced upregulation than CXCL3. Furthermore, co-treatment with PAI-1 and CXCL8 simultaneously enhanced the expression of both genes.

    Plasmid concentration result

    Figure 1: Expression of PLOD2 and LIF in adipocytes treated with PAI-1 and CXCL8.

    Event 5: Cell seeding of human preadipocytes
    Event 5: Cell seeding of human preadipocytes

    We seed the cells into well plates for further adipogenic differentiation.

    Procedures
    1. We seed the preadipocytes in 6 wells of one 6-well plate using cells in 1.5 T25 flask.
    2. The rest cells are passaged in one T25 flask.
    Event 6: Oil Red O staining
    Event 6: Oil Red O staining

    We stained undifferentiated adipocytes to supplement the control groups.

    Procedures
    1. We use the cells in the 6-well plate for Oil Red O staining
    2. Prepare the Oil Red O working solution by mixing the Oil Red O stock solution with distilled water at a 3:2 ratio and thoroughly vortexing the mixture. Filter the solution through filter paper and collect the filtrate, which is the ready-to-use Oil Red O working solution.
    3. After completing the induction of differentiation, carefully aspirate the cell culture supernatant and wash the cells 1-2 times with 1×PBS. Add an appropriate amount of cell fixative and incubate at room temperature for 30 minutes for fixation.
    4. Upon completion of cell fixation, carefully aspirate the fixative solution and wash the cells twice with 1×PBS.
    5. Slowly add Oil Red O staining solution along the well wall, using 1mL per well, and incubate for 30 minutes at room temperature.
    6. After staining, remove the staining solution and rinse with PBS to eliminate non-specific staining.
    Results
    Plasmid concentration result

    Figure 1: Undifferentiated human preadipocytes,with or without oil red o staining.

    2025.09.09-2025.09.15

    Event 1: Cell revival:MDA-MB-231
    Event 1: Cell revival:MDA-MB-231

    We revived the human breast cancer cell line MDA-MB-231 to obtain conditioned medium.

    Procedures
    1. The procedure follows the one in July Week3.
    2. We maintained MDA-MB-231 cells in DMEM supplemented with 10% FBS.
    Event 2: rAAV infection
    Event 2: rAAV infection

    We used rAAV to deliver the PLOD2 sensor,LIF sensor and ADAR to validate the functionality of our RADAR system.

    Procedures
    1. We infected the cells in the 24-well plates (23 wells in total) by 15μL rAAV carrying PLOD2 sensor or LIF sensor, with 5μL rAAV carrying ADAR mixed.
    2. We infected each group with 6 wells.
    Event 3: Cytokine treatment and luminescence detection
    Event 3: Cytokine treatment and luminescence detection

    We treated the cells with cytokines to up-regulate the target gene in adipocytes.

    Procedures
    1. 48 hours post transfection, we treat the cells with PAI-1 and CXCL8.
    2. After cytokines treatment, we collect the supernatant of conditioned medium and detect the luminescence.
    Results
    Plasmid concentration result

    Figure 1:Luminescence of conditioned medium supernatant from infected adipocytes, with or without cytokine treatment.

    Event 4: Conditioned medium collection
    Event 4: Conditioned medium collection

    We seed the MDA-MB-231 cells into 6-well plate to collect the conditioned medium for further experiments.

    Procedures
    1. We seed 6 wells of a 6-well plate with MDA-MB-231.
    2. day after seeding,we exchange the medium to 0.2% FBS DMEM medium and cultured for another 24h.
    3. Then, we collect the conditioned medium and filter using a 0.22 µm filter.
    4. The conditioned medium are stored at -80°C for further experiments.

    2025.09.16-2025.09.20

    Event 1: rAAV infection
    Event 1: rAAV infection

    We used rAAV to deliver the PLOD2-LIF sensor and ADAR to validate the functionality of our RADAR system.

    Procedures
    1. We infected the cells in the 24-well plates (12 wells in total) by 15μL rAAV carrying PLOD2-LIF sensor, with 5μL rAAV carrying ADAR mixed.
    2. We infected 6 wells with above rAAVs.
    Event 2: Cytokine treatment and luminescence detection
    Event 2: Cytokine treatment and luminescence detection

    We treated the cells with cytokines to up-regulate the target gene in adipocytes.

    Procedures
    1. 48 hours post transfection, we treat the cells with PAI-1 and CXCL8.
    2. After cytokines treatment, we collect the supernatant of conditioned medium and detect the luminescence.
    Results

    We observed a significant increase in luminescence intensity in the post-infection culture supernatant following co-treatment with both cytokines, an effect not elicited by individual cytokine treatment or in the absence of cytokines. This confirms that our designed PLOD2-LIF sensor exhibits excellent detection performance and specificity.

    Plasmid concentration result

    Figure 1: Luminescence of conditioned medium supernatant from adipocytes infected by rAAV carry PLOD2-LIF sensor, with or without cytokines treatment.

    Event 3: Conditioned medium treatment and luminescence detection
    Event 3: Conditioned medium treatment and luminescence detection

    We treated the cells with conditioned medium of MDA-MB-231 to detect the efficiency for our engineered adipocytes to detect breast cancer.

    Procedures
    1. 48 hours post transfection, we treat the cells with MDA-MB-231 CM,with 0.2%FBS DMEM treatment as a control.
    2. Then, we collect the supernatant of conditioned medium and detect the luminescence.
    Results

    We observed that MDA-MB-231 conditioned medium (CM) induced a significant increase in luminescence intensity, indicating that our detection system functions effectively.

    Plasmid concentration result

    Figure 1: Luminescence of conditioned medium supernatant from adipocytes infected by rAAV carrying PLOD2-LIF sensor and ADAR, with or without CM treatment.

    Event 4: Measurement of cell viability by CCK-8 assay
    Event 4: Measurement of cell viability by CCK-8 assay

    We assessed the impact of rAAV infection on cell viability using the CCK-8 assay.

    Procedures
    1. Thaw CCK-8 solution and protect from light (wrap in foil).
    2. Add 50μL CCK-8 reagent per well.
    3. Return plate to CO2 incubator for 2h.
    4. Collect the supernatant, transferred to a 96-well plate, and its absorbance was measured at 450nm using a microplate reader.
    Results

    We observed no significant change in the viability of adipocytes following infection with rAAV carrying the PLOD2-LIF sensor and ADAR.

    Plasmid concentration result

    Figure 1:The viability of infected and uninfected adipocytes revealed by CCK-8 assay.

    Dry Lab
    December
    Model group member recruitment
    2024.11.24-2024.12.22

    After the team recruitment, our model group was set up by three outstanding undergraduate students from Jilin University, Hanqiu Yang from the School of Computer Science and Technology, Wenyuan Deng from the School of Mathematics and Chenguang Shi from the Third Bethune Clinical Medical College.

    CJUH-JLU-China First Full Group Meeting
    2024.12.23-2025.01.04

    During the group meeting, members of the Model group met offline for the first time and made their choices regarding the research directions during the brainstorming phase: Hanqiu Yang chose the research direction of large sequence models, while Wenyuan Deng opted for the direction of biomolecular dynamics simulation,and Chenguang Shi chose bioinformatics analysis as his research direction. Moving forward, the members will engage in learning and replication in their respective fields of interest, gradually accumulating experience.

    January
    The First Online Meeting of the Model Group (The First Brainstorm)
    2025.01.05-2025.01.19

    At the first meeting of the Model group, Hanqiu Yang reported on his learning progress, which covered knowledge such as fully connected neural networks in deep learning. He also researched the application direction of large sequence models in synthetic biology and proposed the application of AI in the Wiki group. Wenyuan Deng shared her learning experience with MATLAB and simbiology, analyzed and replicated the case of the 2023 AFCM - Egypt Best Model nominee, pointed out the advantages and disadvantages of the case as well as the direction for improvement, and meanwhile, stated the existing problems and the subsequent plan. Chenguang Shi shared the application of programming software such as R and Python in bioinformatics analysis.Consultant Renxiu Song and the former leader of the Model group, Haoyang Liu, shared their Model competition experience and put forward corresponding suggestions for improvement.

    Figure 1:Screenshot of the PPT for the First Online Group Meeting
    Preliminary preparation and the exploration of principles of models
    2024.12.23-2025.01.26

    During the initial phase of the Model group's activities, members established foundational research directions through brainstorming and collaborative discussions. Domains of large sequence models and biomolecular dynamics simulation through tools like MATLAB and SimBiology are studied by team members. Our work also includes the case studies of best model nominees such as the 2023 AFCM - Egypt and 2021 Vilnius. Subsequently, we learnt the mathematical principles of Transformer architecture, reproducing self-attention mechanisms and explored applications of large-scale models in gene sequence analysis. Furthermore, we also advanced our proficiency in non-compartmental analysis and parameter fitting using SimBiology's Model Analyzer.

    Figure 2: Screenshot of the PPT for the Second Online Group Meeting.
    February
    Data search
    2025.02.17-2025.02.23

    This week, we officially began the search work in the database with the EXP team. We systematically learned the use of databases such as GEO, TCGA, GTEx, and ArrayExpress. After comprehensive consideration, we ultimately chose GEO, TCGA, and GTEx as our available databases.

    Figure 1:GEO, TCGA, GTEx Databases
    Determine the data source
    2025.02.24-2025.03.03

    After analysis, we found that the GEO database data has issues such as small scale, which is difficult to meet our work needs. Therefore, we ultimately decided to search for the required data from TCGA and GTEx.

    Figure 2: Analysis Conducted on GEO
    March
    Through literature research, we have identified several genes which exhibit abnormal expression in adipocytes after being affected by breast cancer cells.
    2025.03.04-2025.03.10

    Through literature research, we have identified several genes which exhibit abnormal expression in adipocytes after being affected by breast cancer cells.

    Figure 1:Relevant Literature
    Determination of Gene Combination for Monitoring
    2025.03.11-2025.03.28

    Utilizing an MLP algorithm incorporating the Attention mechanism-better suited to capture complex non-linear relationships in high-dimensional sparse data-we performed feature extraction on the data matrix. Based on data from TCGA and GTEx, we evaluated the predictive performance of different gene combinations and ultimately determined the gene combination for subsequent monitoring.

    Fighure2: ROC Curve of the Top 5 Gene Combinations.
    April
    Preliminary Work and Exploration on the Construction of Ethical Risk Assessment Model
    2025.03.29-2025.04.06

    This week with the HP team, we developed a Synthetic Biology Ethical Risk Assessment Model. Current research remains qualitative (philosophy/social science) with no standardized risk grading or mathematical models. Proposed solutions (ethical matrices, AI evaluation, structural equation modeling) all face challenges like subjective quantification. Next week focuses on feasibility analysis and preliminary modeling.

    Figure 1:Exploring modeling approaches for ethical risk assessment in collaboration with the HP.
    Case Analysis and Model Exploration on the Construction of Ethical Risk Assessment Model
    2025.04.07-2025.04.15

    This week, we made further progress on our synthetic biology ethical risk assessment mode. we adopted a hybrid approach combining mathematical modeling with Likert-scale questionnaires covering biosafety and social equity dimensions. Our next steps involve applying structural equation modeling to analyze latent variables through path coefficients for quantitative validation.

    Figure 2: Screenshot of the PPT for Online Group Meeting
    Structural Design Optimization and Model Exploration
    2025.04.16-2025.04.24

    we finalized the adoption of a Structural Equation Modeling (SEM) + Bayesian Network hybrid approach. After deepening our theoretical understanding of SEM, we established a dual-track strategy combining mathematical modeling with questionnaire surveys. This involves: 1) collecting data through customized questionnaires to analyze key influencing factors and their path coefficients, 2) developing quantitative assessment models, and 3) exploring Bayesian Network-SEM integration with proposed linear/Sigmoid mapping solutions for weight-to-probability conversion. Collaborating with the HP team, we refined ethical assessment dimensions in the questionnaire.

    Figure 3: Screenshot of the PPT for Online Group Meeting.
    May
    Building and Expanding the Model through Preliminary Questionnaire Collection and Data Validation
    2025.04.25-2025.05.07

    In our seventh team meeting, we finalized a comprehensive modeling framework integrating multi-dimensional variables through Structural Equation Modeling (SEM) and Bayesian Networks to evaluate both the potential impact and occurrence probability of ethical risks. Building on established evaluation dimensions and indicators from literature, we've successfully designed and distributed questionnaires, collecting 322 diverse samples. For SEM implementation, we've completed data simulation tests yielding path diagrams and reliability indices, while for Bayesian Networks, we've established fundamental principles including weight-to-probability conversion methods and risk assessment procedures using Bayesian inference.

    Figure 1: Exchanging perspectives with the HP on
    ethical risk assessment model construction
    Transitioning to Bayesian Networks
    2025.05.08-2025.05.16

    In the ethical risk assessment model, we transitioned from structural equation modeling to Bayesian networks. This involved converting path coefficients to form a topological structure, discretizing continuous variables, and applying softmax normalization to build a conditional probability table. We also began learning to use Netica software.

    Figure 2: the Photos of Group Meeting.
    Bayesian Network Application
    2025.05.17-2025.05.24

    We have established an ethical risk assessment system and developed a generalized synthetic biology risk assessment model based on structural equation and Bayesian network, achieving risk quantification.

    Figure 3: the Photos of Group Meeting and Bayesian Network.
    June
    Case Validation of the Ethical Risk Assessment Model
    2025.05.25-2025.06.02

    We designed a universal questionnaire within our ethical risk assessment model and used two case studies-"synthetic reconstruction of the smallpox virus" and "producing the antimalarial drug artemisinin(青蒿素) with synthetic yeast"-to test the model's validity. Through this process, we successfully generated the corresponding Bayesian network diagrams, which verified that the model is sound and reasonable.

    Figure 1: the results of Bayesian network.
    Model Framework Refinement and Project Self-Assessment
    2025.06.03-2025.06.11

    We further refined the overall framework of the ethical risk assessment model, creating its flowchart and drafting the relevant documentation. Concurrently, we conducted an ethical risk assessment on our own project using the model, ultimately concluding that our project is categorized as low-risk.

    Figure 2: Framework and the result of Bayesian network.
    Ethical Assessment System Documentation Refinement
    2025.06.12.-2025.06.22

    This week, we finalized the name "BEAM" (Bio-ethical Assessment Model) for our ethical assessment model, intending to illuminate ethical evaluation in synthetic biology. Subsequently, we revised and discussed the documentation outline.

    Figure 3: The Photos of BEAM Framework and Logo.
    Design of sensor-RNA Sequences
    2025.06.23-2025.06.30

    Upon obtaining the key gene combination, we designed multiple sensor-RNA sequences for plasmid construction based on their expression profiles. We employed the iPKnot++ algorithm, capable of predicting long-chain RNA structures including pseudoknots, to simulate RNA secondary structures. We quantitatively evaluated the functionality of the RNA sequences using two metrics: the unpaired probability in the sensor region and the exposed length near editing sites. Ultimately, we determined the sensor-RNA sequences for plasmid construction.

    Figure 4: Reference of iPknot++ and simulation of RNA secondary structure.
    July
    Preliminary Construction of the RADAR System Dynamics Model
    2025.07.01.-2025.07.07

    This week, we established the preliminary dynamic model of the RADAR system based on the previously designed RNA sensors. By abstracting the RNA editing and downstream reporter expression process, we obtained the overall reaction framework and formulated an equation system for subsequent validation.

    Figure 1: RADAR System Response Process.
    RADAR System Simulation
    2025.07.08.-2025.07.14

    We noticed that the data scale of the GEO database was insufficient for our needs. After screening, we identified TCGA (The Cancer Genome Atlas) and GTEx (Genotype-Tissue Expression) as the primary data sources.

    Figure 2: Simulation Curves of RADAR.
    Preliminary Construction of GLUC Renal Filtration Membrane Model
    2025.07.15.-2025.07.21

    This week, we focused on the dynamic process of GLUC in the glomerular filtration barrier. By modeling the structural features and diffusion mechanisms, we demonstrated how GLUC molecules pass through the filtration barrier and obtained the concentration change trends in body fluids.

    Figure 3: Schematic of GLUC Filtration Model
    Dry Lab Documentation Refinement
    2025.07.22.-2025.07.28

    This week,We have not only validated the RADAR response pattern at the cellular level but also demonstrated the feasibility of GLUC as a detectable output signal. Our model is named DISCERN, signifying "Dynamic Integration of Simulation for Cancer Evaluation and Recognition," while also embodying the meaning of "discernment and recognition."

    Figure 4: The Photo of Discern Logo.
    August
    Backend Algorithm Implementation
    2025.07.29 - 2025.08.08

    This week, we focused on refining the core algorithm logic, completing the code implementation for data processing and modeling, and conducting preliminary performance tests.

    Figure 1: Code Snippet.
    Frontend Development and Functionality Debugging
    2025.08.09 - 2025.08.19

    We established the frontend framework and designed the overall webpage structure, achieving seamless integration with the backend. Page interaction optimization and visual design adjustments were implemented to ensure clarity, aesthetics, and functionality. Initial functional testing was initiated to identify and resolve issues in frontend-backend interaction.

    Figure 2: Webpage Design Optimization.
    Bug Fixes and Software Documentation
    2025.08.20 - 2025.08.31

    This week, we systematically addressed bugs identified during testing and optimized the code to enhance overall stability and efficiency. Concurrently, we drafted the accompanying Software webpage documentation.

    September
    Final Refinement and Conclusion
    2025.09.01 - 2025.09.07

    We conducted a final round of testing and functionality verification. Files were organized, documentation formats were finalized, and the submission version was prepared.

    HP & Edu
    December
    HP & Education group member recruitment
    2024.12.4-2024.12.7

    After the recruitment process, 7 undergraduates from Jilin University have joined the HP & Education group of the 2025 CJUH-JLU-China iGEM team.

    January
    Braille reading materials production
    2025.1.7-2025.1.9

    We successfully transformed and printed the 2024 original team-created picture book "Invisible Bacteria" into a Braille version through the Comet-Light Hanbilingual Translation Platform. This provided unique biological science popularization educational content for visually impaired children.

    Figure 1: Braille reading materials.
    Synthetic biology Winter Camp
    2025.1.9-2025.1.12

    The "Explore the code of life and program a journey into synthetic biology" synthetic biology fun camp was held in the Song Zhiping Gymnasium of Jilin University, attracting teenagers curious about life sciences to participate.

    Figure 2: Synthetic Biology Fun Camp in winter.
    Return-to-school promotion activities
          2025.1.16-2025.1.21

    As the winter vacation arrives, our team members carried out several lectures back at their high schools which shaped and cultivated them, with the aim of inspiring curiosity and enthusiasm in synthetic biology and scientific research among the young talents.

    Gene Component Auction lecture
    Figure 3: Lecture on the theme of "Synthetic Future, Innovators Say" by Wenxian Gao.
    Figure 3: Lecture on the theme of "Synthetic Future, Innovators Say" by Wenxian Gao.
    Planting the Seeds of Synthetic Biology lecture
    Figure 4: Promotional speech of iGEM by Jingzhe Yu.
    Figure 4: Promotional speech of iGEM by Jingzhe Yu.
    Biologyand The Art of Synthesis lecture
    Figure 5: Online promotional speech of iGEM by Jiayu Cong.
    Figure 5: Online promotional speech of iGEM by Jiayu Cong.
    February
    Listening to the Community
    2025.2.9-2.11

    We explored public health needs in several communities in Changchun, including Qunying, Huxi, and Nanling Baiyi. Surveys and interviews revealed strong concern about breast cancer, especially around early detection and current diagnostic limitations. Patients expressed the need for better awareness, less invasive screening, and more accessible technologies. These insights guided our project toward developing improved, patient-centered breast cancer diagnostics.

    Figure 1: Public interviews in three communities.
    Understanding Public Health Needs in Yanbian
    2025.2.12-2.14

    After learning about breast cancer challenges in the Yanbian Korean Autonomous Prefecture, we visited the local CDC for more information. They shared issues like limited medical resources and gaps in disease monitoring. Although screening programs exist, effective follow-up for breast cancer remains a major challenge. Current methods may miss early recurrence or cause unnecessary anxiety. This inspired us to develop a technology for long-term in vivo monitoring with easy at-home readouts, aiming to make follow-up care more accessible and reliable.

    Figure 2: Exchange activity with Yanbian State CDC and residents.
    Strengthening Our Idea at the MedTech Summit 2025
    2025.2.15-2.17

    To find suitable technologies for our in vivo monitoring with in vitro readout system, we attended the MedTech Summit 2025. The conference focused on medical innovation and patient-centered care. We discovered that combining in vitro diagnostics (IVD) with implantable sensors and external readers offers a faster, easier, and less invasive way to monitor breast cancer. One key idea we learned was "real-time early warning", which uses continuous monitoring and smart analysis to catch problems early. This inspired us to include real-time features in our design to improve early detection, reduce patient burden, and support long-term follow-up care.

    Figure 3: Attend the MedTech Summit 2025 online.
    Interview with Dr. Guang Sun, Breast Surgery Department
    2025.2.17-2.21

    We interviewed Dr. Guang Sun from Jilin University to get clinical feedback on our project. He explained that breast cancer detection in China has improved with imaging, but many areas still have limited screening and low patient compliance. He pointed out two main problems: the high chance of cancer returning, especially in aggressive types, and weak long-term follow-up systems. Dr. Sun agreed that the focus is moving from early detection to preventing recurrence and improving long-term care, which supports our project’s goals.

    Figure 4: Interview with Dr. Guang Sun, Breast Surgery Department.
    Interview with Dr. Wan Wang, Breast Surgeon
    2025.2.22-2.24

    Noticing the rise in breast reconstruction surgeries, we explored integrating a diagnostic system with reconstruction to aid both monitoring and recovery. After consulting Dr. Wan Wang from Jilin University, we learned that autologous fat grafting is widely used and feasible for implanting engineered adipocytes during surgery. Although breast-conserving surgery rates are relatively low and immediate reconstruction even lower, this approach offers a promising integrated diagnosis and treatment strategy for patients undergoing reconstruction.

    Figure 5: Interview with Dr. Wan Wang, Breast Surgeon.
    Interview with Dr. Lianbo Zhang, Plastic Surgeon
    2025.2.25-2.27

    To expand our project’s impact beyond breast cancer patients undergoing reconstruction, we explored the use of autologous fat grafting in cosmetic breast augmentation. Guided by insights from plastic surgeon Dr. Lianbo Zhang, we learned that fat grafting is both clinically safe and increasingly popular due to its natural results and minimal invasiveness. Based on this, we decided to broaden our target group to include women choosing cosmetic augmentation, using fat grafting as a platform to extend the application of our diagnostic technology.

    Figure 6: Interview with Dr. Lianbo Zhang, Plastic Surgeon.
    Interview with Dr. Bin Yang, Breast Surgeon
    2025.2.28-3.1

    While evaluating output options for our system, we compared melanin and Gaussia luciferase (Gluc) in terms of user convenience and psychological impact. Through an interview with Dr. Bin Yang, we learned that visible melanin marks could negatively affect body image, while Gluc offers a non-invasive and technically feasible luminescent readout. Based on this, we chose Gluc as our reporter gene and confirmed its sensitivity and practicality through lab tests. Its ability to produce detectable signals in body fluids like urine supports its potential for real-world, patient-friendly monitoring.

    Figure 7: Interview with Dr. Bin Yang, Breast Surgeon.
    Knowledge sharing program at at Huxi Community
    2025.2.1-2.4

    At the Huxi Community, Changchun, we held a discussion-focused outreach, bringing together thirteen community members to explore the applications of synthetic biology and ethical considerations.

    Figure 1: Community knowledge sharing program.
    Education wiki refinement
    2025.2.12-2025.2.15

    Our team discussed how to improve the layout and content presentation of our Education wiki. Ideas include embedding scroll-triggered animations, hand-drawn comics, real-time online graffiti walls and many more.

    Figure 2: Edu wiki improvement solution.
    March
    Interview with Professor Walter Bodmer, Fellow of the Royal Society
    2025.3.5-3.11

    We began by exploring public databases to identify genes highly expressed in cancer-associated adipocytes (CAAs), but the available datasets were limited in size and lacked strong statistical power. After consulting Professor Walter Bodmer, we learned that observed gene expression might reflect general inflammation rather than breast cancer specificity.

    Figure 1: Interview with Professor Walter Bodmer, Fellow of the Royal Society.
    Interview with Project Manager at DIRUI
    2025.3.23-3.29

    To select suitable cancer biomarkers, we consulted DIRUI Industrial Co., Ltd., a company experienced in tumor marker detection. Their experts emphasized the importance of accuracy and shared strategies to optimize screening and reduce false positives. Inspired by this, we adopted a combined biomarker approach and identified four candidate gene pairs from literature.

    Figure 2: Interview with Project Manager at DIRUI.
    Interview with Research Scientist Hongyu Wu
    2025.3.12-3.16

    We consulted Dr. Wu, an expert in molecular biology, to assess the feasibility of using adenovirus for gene delivery in adipocytes. She confirmed adenovirus's high infection efficiency but noted its short-lived expression, potential immune response, and reduced effectiveness in adipose tissue. Based on her advice, we switched to adeno-associated virus (AAV) for its lower immunogenicity and better stability in non-dividing cells.

    Figure 3: Interview with research scientist Hongyu Wu.
    1st WeChat press release
    2025.3.6

    We published the first WeChat official account post displaying the 2025 CJUH-JLU-China team recruitment activity.

    Figure 1: 1st WeChat press release.
    2nd WeChat press release
    2025.3.13

    We published the second WeChat official account post titled "Synthesizing the Future: Voice of Innovators", kicking off our iGEM promotion series.

    Figure 2: 2nd WeChat press release.
    "Super Little Inventor" education activity
    2025.3.14

    We carried out the "Super Little Inventor" educational activity in Jilin University Affiliated Primary School, aiming to inspire children's interest in exploring the world of biology by designing "super little creatures".

    Figure 3: "Super Little Inventor" education activity.
    3rd WeChat press release
    2025.3.20

    We published the third WeChat official account post, with the theme of "the Innovative Blueprint of Synthetic Biology and Cell Factories".

    Figure 4: 3rd WeChat press release.
    Debate on Ethics of IP in Synthetic Biology
    2025.3.23

    To spark deeper reflection on syn-bio ethics and innovation, we hosted a debate centered the ethical implications of IP openness in synthetic biology, and invited the debate team from JLU School of Business and Management as our counterpart.

    Figure 5: Intellectual Property Debate Competition.
    April
    Interview with Professor Yunsheng Dong
    2025.4.2-4.15

    To overcome the challenge of balancing subjective judgment and objective criteria in constructing our ethical risk assessment framework, we sought guidance from Prof. Dong, a specialist in philosophy and sociology. He emphasized the importance of scenario-specific ethical assessments, as ethical concerns vary by application. Following his advice, we refined our framework. This made our framework more targeted, practical, and adaptable.

    Figure 1: Interview with Professor Yunsheng Dong.
    Interview with Professor Wenbin Chen
    2025.4.16-4.24

    While developing our ethical risk assessment framework, we initially built a multi-dimensional system and used Structural Equation Modeling (SEM) to determine the weight of each factor. However, we faced challenges in quantitatively assessing uncertain risks based on these dimensions. To address this, we consulted Prof. Wenbin Chen, who advised us to explore probabilistic relationships among factors. Following his guidance, we introduced a Bayesian network, which enabled dynamic risk inference and improved adaptability. .

    Figure 2: Interview with Professor Wenbin Chen.
    Survey on Ethical Perceptions of Synthetic Biology
    2025.4.25-4.26

    After analyzing ethical issues across different scenarios, we recognized that expert perspectives alone were insufficient for a comprehensive evaluation. To incorporate public perception, we designed a detailed questionnaire covering key ethical dimensions and attitudes toward emerging synthetic biology applications. The collected data became the foundation for our model, offering both insights into public concerns and quantitative input for model training. This step helped bridge expert analysis with societal expectations, ensuring our framework remains grounded and socially relevant.

    Figure 3: The Questionnaire on Ethical Concepts in Synthetic Biology.
    Attending the International Academic Exchange Conference on Plastic Surgery, "China-Korea Plastic Surgery Academic Salon"
    2025.4.27-4.28

    We attended the China-Korea Plastic Surgery Academic Salon to gain insight into the needs and business models of plastic surgery departments in public hospitals. Dr. Lianbo Zhang’s presentation provided key insights into clinical evaluation standards in public hospitals, emphasizing practicality, evidence, and protocol alignment. This guided us to pursue research collaborations and clinical validation. Additionally, Dr. Haiyan Qin’s talk helped us identify a technical pathway to integrate our project into medical aesthetics.

    Figure 4: Attending the China-Korea Plastic Surgery Academic Salon.
    Interview with Dr. Zhao, president of the private medical aesthetics clinic Jingdian Medical Beauty
    2025.4.3

    To better understand the needs of private medical aesthetics clinics, we interviewed Dr. Zhao, who emphasized that fat cell survival is crucial for successful breast augmentation and patient satisfaction. She pointed out the industry's challenge of unstable fat cell survival, which could hinder the adoption of ABCS. In response, we identified improving the survival rate of engineered fat cells during transplantation as a key research focus, aiming to optimize methods tailored.

    Figure 5: Interview with Dr. Zhao.
    "Fuzzy Sticks" education activity
    2025.4.3

    We held the "Fuzzy Sticks" education activity at Changchun Jilong Middle School. Through creative hands-on practice, we led students into the fascinating world of synthetic biology and helped them experience the unique charm of science and innovation.

    Figure 1: "Fuzzy Sticks" education activity.
    1st post on REDnote
    2025.4.4

    We established the REDnote account and published our first post, briefly introducing our team and our past highlight moments.

    Figure 2: 1st post on REDnote.
    4th WeChat press release
    2025.4.5

    We released the fourth WeChat official account post, displaying our visit to the Changchun International Medical and Health Industry Expo and our exploration of the public's understanding on medical and health.

    Figure 3: 4th WeChat press release.
    The "Cell Kingdom on Kites" education activity
    2025.4.11

    We conducted the Cell Kingdom on Kites education activity at Jilin University Affiliated Primary School. We introduced the kids to a variety of cells and organelles, explained how they work, and let them illustrate their favorite cells on kites, aiming to guide children in exploring microscopic world mysteries and feel the unique charm of the collision between science and art.

    Figure 4: The "Cell Kingdom on Kites" education activity.
    5th WeChat press release
    2025.4.12

    We released the fifth WeChat official account post, centering the past and the present of synthetic biology.

    Figure 5: 5th WeChat press release.
    The "Letter Exchange Across the Nation" activity
    2025.4.13

    Through the platform of Jilin University, we reached out to students at multiple universities nationwide through open letters, sharing our team's iGEM journey last year to spark their interest in iGEM and synthetic biology.

    Figure 6: the "Letter Exchange Across the Nation" activity.
    2nd post on REDnote
    2025.4.13

    We released the second post on REDnote, introducing the cycle and award settings of the iGEM competition.

    Figure 7: 2nd post on REDnote.
    6th WeChat press release and 3rd post on REDnote
          2025.5.1-2025.5.25

    We released the sixth WeChat official account post and the third post on REDnote, introducing the whole process of the Apricot Blossom Festival (an annual tradition here in JLU) in detail.

    Gene Component Auction lecture
    Figure 8: 6th WeChat press release.
    Planting the Seeds of Synthetic Biology lecture
    Figure 9: 3rd post on REDnote.
    The "Spring in Pinwheels, Nature in Slides" activity
    2025.4.20

    On the occasion of the 10th apricot blossom festival of Jilin University, we held the "Spring in Pinwheels, Nature in Slides" activity at the Nanling campus, Jilin University. Faculty and students actively participated, experiencing the integration of science and spring’s beauty.

    Figure 10: Pictures at the activity site.
    The "Cell Chess" game
    2025.4.24

    We developed the educational game "Cell Chess" and engaged international students in the chess play, enabling them to discover biology’s wonders.

    Figure 11: the "Cell Chess" game with international students.
    7th WeChat press release
    2025.4.26

    We released the seventh WeChat official account post, reviewing the memorable moments in the Apricot Blossom Festival, from DIY windmills to a magical world under a microscope, we have achieved a vivid interaction between spring and science.

    Figure 12: 7th WeChat press release.
    Synthetic Biology in Seven Days-Advanced Edition - Chapter 1 Video
    2025.4.27

    We recorded a video explaining the first chapter of the learning material, focusing on the concept of iGEM, its development history, and the award settings.

    Figure 13: Chapter 1 video cover.
    4th post on REDnote
    2025.4.27

    We released the fourth post on REDnote, presenting the wonderful moments of the Apricot Blossom Festival event.

    Figure 14: 4th post on REDnote.
    May
    Attending the Symposium on Clinical Research and Overseas Expansion of China’s New Drug R&D in the New Environment
    2025.5.17-6.4

    As the ABCS project approached commercialization, we sought to bridge the gap between research, clinical application, and market readiness by attending a symposium on clinical research and new drug development. There, we developed a multi-dimensional strategy involving small-scale clinical trials to improve system stability, a tiered market approach targeting both hospitals and consumer channels, and plans to co-develop supporting equipment.

    Figure 1: Participating Online in the Symposium.
    8th WeChat press release
    2025.5.1

    We released the eighth WeChat official account post, centering the introduction to some of the iGEM villages.

    Figure 1: 8th WeChat press release.
    The "Science Carnival on Snakes and Ladders" education activity
    2025.5.8

    We conducted a science popularization activity for students of Dehui Experimental Primary School, introducing human cells, cell organelles, and Escherichia coli. Then, we designed the Snakes and Ladders Q&A activity, combining education with entertainment to arouse students' curiosity about exploring biological mysteries.

    Figure 2: The "Science Carnival on Snakes and Ladders" education activity.
    9th WeChat press release
    2025.5.10

    We released the ninth WeChat official account post, introducing the whole process of the "Yinyin Journey" grassland music festival in detail and the gameplay of snakes and ladders.

    Figure3: 9th WeChat press release.
    The first session of the SUSTech-SynBio Community Exchange
    2025.5.10

    We participated in the first session of the SUSTech-SynBio Community Exchange as the invited guest, sharing this year's project design and the Human Practices experience in 2024.

    Figure 4: The first session of the SUSTech-SynBio Community Exchange.
    5th post on REDnote
    2025.5.11

    We released the fifth post on REDnote, documenting the wonderful moments of the Apricot Blossom Festival (an annual tradition here in JLU) in the form of a video.

    Figure 5: 5th post on REDnote.
    The "Bio-Melody" - Science Outreach at the Grassland Music Festival
    2025.5.11

    On the occasion of the "Yinyin Journey" grassland music festival at Jilin University, we held a variety of scientific activities at the Xinmin Campus of Jilin University such as SynBio&Smile smiley face board to immerse participants in a joyful atmosphere of science and music fusion.

    Figure 6: Photos at the activity site.
    The 2nd Northeast Regional iGEMer Exchange Conference
    2025.5.11

    We participated in the second Northeast Regional iGEMer Exchange Conference, sharing this year's projects and listening to the insightful views of other teams on experimental techniques, project design and other aspects.

    Figure 7: The 2nd Northeast Regional iGEMer Exchange Conference.
    The "Life Code Designer" education activity
    2025.5.12

    We guided high school students from Dehui Experimental High School to briefly understand what synthetic biology is and its fascinating inventions. Using common daily-life phenomenon as a gateway to introduce synthetic biology, we encouraged students to unleash their imagination and create simple synthetic biology designs.

    Figure 8: The "Life Code Designer" education activity.
    Educational activity at Dehui Special Education School
    2025.5.14

    Using daily-life phenomenon as the starting point, we introduced bacteria to children at Dehui Special Education School. We guided them to collaboratively create bacteria models with plasticine. Despite many facing self-care challenges, they cooperated warmly, sharing genuine smiles. These children, like angels with folded wings, may find in biology an interest that fuels their journey ahead, inspiring them to persevere.

    Figure 9: Educational activity at Dehui Special Education School.
    Exchange conference with Fudan University iGEM team
    2025.5.16

    We exchanged with Fudan University iGEM team, reaching a consensus on cooperation.

    Figure 10: Exchange conference with Fudan University iGEM team.
    6th post on REDnote
    2025.5.17

    We released the sixth post on REDnote, reviewing the gains from the 2nd Northeast Regional iGEMer Exchange Conference.

    Figure 11: 6th post on REDnote.
    "Plasmid Construction, Campus Orienteering" Challenge
    2025.5.18

    We developed the "Plasmid Construction, Campus Orienteering" to promote synthetic biology by orienteering while collecting plasmid fragments at different sites and eventually completing a plasmid at the finishing line.

    Figure 12: "Plasmid Construction, Campus Orienteering" Challenge.
    10th WeChat press release
    2025.5.18

    We released the tenth WeChat official account post as a supplement to the eighth post, centering the introduction to the rest iGEM villages.

    Figure 13: 10th WeChat press release.
    11th WeChat press release
    2025.5.24

    We released the eleventh WeChat official account post, reviewing the moments at the second Northeast Regional iGEMer Exchange Conference.

    Figure 14: 11th WeChat press release.
    7th post on REDnote
    2025.5.26

    We released the seventh post on REDnote, reviewing our highlights at the grassland music festival.

    Figure 15: 7th post on REDnote.
    Synthetic Biology in Seven Days-Advanced Edition - Chapter 2 Video
    2025.5.28

    We recorded a video explaining the second chapter of the learning material, focusing on the award criteria of the iGEM competition and conducted case interpretation on some special awards.

    Figure 16: Chapter 2 video cover.
    June
    ABCS Ethical Risk Assessment
    2025.6.5-6.13

    We conducted a survey to assess how different stakeholders perceive the ethical risks and benefits of the ABCS system. This targeted survey aligned directly with BEAM indicators, transforming the model from a theoretical framework into a practical assessment tool. The results revealed differing concerns among experts, patients, and the public, allowing us to adjust risk weights and develop the ABCS Ethical Risk Assessment.

    Figure 1: The ABCS Ethical Risk Assessment Questionnaire.
    Interview with Director Jun Wei of the Ethics Committee
    2025.6.14-6.23

    We recognized the importance of breast cancer patients’ firsthand insights but faced challenges related to handling sensitive personal data during interviews. To ensure ethical compliance and protect patient rights, we consulted Wei Jun from the Ethics Committee. He advised us to standardize interview procedures and improve the informed consent form for clarity and transparency. Following his guidance, we revised the consent document to clearly explain the interview purpose, data use, and privacy protections in patient-friendly language.

    Figure 2: Interview with Director Jun Wei and the Informed Consent Form.
    Interview with Professor Yujiao Jia
    2025.6.24-6.27

    We encountered challenges in respecting patients’ subjectivity and fostering equal dialogue. To address this, we consulted Prof. Yujiao Jia, an expert in philosophy and social sciences. She recommended using a narrative cognitive theory-based life history interview method, involving multi-layered questioning to capture patients’ experiences fully. Prof. Jia also emphasized the importance of suspending the interviewer’s authority, promoting humility, and engaging in open, jargon-free conversations to truly honor patients as narrators of their own lives.

    Figure 3: Interview with Professor Yujiao Jia.
    Interview with Dr. Zijun Zhou, a specialist in breast surgery
    2025.6.28-6.29

    As we prepared for in-depth interviews with breast cancer patients, we recognized that technical readiness alone was insufficient due to the patients’ complex psychological states. To address this, we consulted experienced breast surgeon Dr. Zhou who shared insights on patients’ common psychological challenges-identity confusion, anxiety about recurrence, and social withdrawal-and offered communication strategies emphasizing empathy and active listening.

    Figure 4: Interview with Dr. Zijun Zhou.
    Interview with the AI Simulated Patient
    2025.6.30-7.7

    Before actually interviewing patients, we were still concerned that our approach might not be mature enough and could unintentionally cause secondary emotional harm. So, we decided to use Doubao AI to help us assess whether our interview style met the requirements suggested by the experts we consulted.

    Figure 5: Interview with the AI Simulated Patient.
    The second iBridge exchange meeting
    2025.6.1

    We participated in the second iBridge exchange meeting, presenting this year's projects and sharing the competition experiences with other teams.

    Figure 1: Screenshot of the online meeting.
    Virtual laboratory-1: Preparation of competent cells
    2025.6.3

    We have completed the virtual experiment of competent cells preparation, and completed the interface layout design of the virtual laboratory.

    Figure 2: Virtual laboratory-1: Preparation of competent cells.
    8th post on REDnote
    2025.6.10

    We released the eighth post on REDnote, describing the detailed work content of each group in our iGEM team.

    Figure 3: 8th post on REDnote.
    Virtual laboratory-2: Bacterial transformation
    2025.6.12

    We completed the virtual experiment of bacterial transformation, and carried out the function test and performance optimization.

    Figure 4: Virtual laboratory-2: Bacterial transformation.
    12th WeChat press release
    2025.6.14

    We released the twelfth WeChat official account post, reviewing our highlights at the grassland music festival.

    Figure 5: 12th WeChat press release.
    Synthetic Biology in Seven Days-Advanced Edition - Chapter 3 Video
    2025.6.20

    We recorded this video to explain the third chapter of the learning material, focusing on the concept and key points of synthetic biology.

    Figure 6: Chapter 3 video cover.
    13th WeChat press release
    2025.6.28

    We released the thirteenth WeChat official account post, centering the CRISPR gene editing technology.

    Figure 7: 13th WeChat press release.
    Virtual laboratory-3: DNA digestion and ligation
    2025.6.29

    We have completed the process decomposition, animation production and algorithm implementation of DNA digestion and ligation experiment, aiming to establish a virtual experiment platform and integrate popular science game elements.

    Figure 8: Virtual laboratory-3: DNA digestion and ligation.
    July
    Interview with Professor Ling Ren from the School of Business
    2025.7.8-7.9

    We faced challenges in defining our marketing strategy. To address this, we consulted Prof. Ren Ling from the School of Business, who advised us to adopt a phased approach-starting with ToB technical services before expanding to ToC products. Guided by her insights, we formulated a market segmentation strategy.

    Figure 1: Interview with Professor Ling Ren and the Business Canvas for ABCS
    Interview with Mr. Xue
    2025.7.10-7.12

    We realized the challenge lay in effectively communicating our technical value to investors. To address this, we interviewed Mr. Xue, an expert in biotech investment and entrepreneurship. He emphasized the importance of storytelling-translating technical strengths into accessible language, linking them to market needs, and showcasing both commercial potential and social impact. Based on his advice, we developed the "ABCS Brand Strategy House" to clearly articulate our value proposition and enhance investor appeal.

    Figure 2: Interview with Mr. Xue and the "ABCS Brand Strategy House"
    Interview with the Human Resources Manager of Guangzhou Wonfo Biotechnology Co., Ltd
    2025.7.13-2025.7.14

    To better understand how to build a talent system aligned with commercialization goals, we consulted executives from Wondfo, a company experienced in medical innovation. They emphasized the importance of interdisciplinary talent and shared strategies like cross-functional collaboration, departmental rotation, and integrated workshops. Inspired by their insights, we created a tailored talent development plan for the ABCS project.

    Figure 3: Interview with the HR of Wondfo Biotechnology Co., Ltd.
    Interview with Professor Haoran Yu, Department of Mathematics
    2025.7.15-7.16

    To evaluate Gluc’s renal clearance efficiency, we planned to simulate its transport across the glomerular filtration barrier but faced two data gaps: no literature on Gluc’s filtration rate and no basement membrane pore size distribution data, so we consulted Prof. Haoran Yu. He suggested using the normal distribution of stochastic biological structures and the barrier’s known physical parameters to reasonably assume the basement membrane’s pore size, and further recommended coupling macro renal clearance data with micro structural modeling.

    Figure 4: Interview with Professor Haoran Yu, Department of Mathematics
    Interview with Senior Researcher Yin Rui
    2025.7.17-7.31

    Via literature review, we noted GFB is traditionally 3-layered. After confirming the first two layers’ parameters, we faced unresolvable discrepancies in the third layer’s reported parameters. We then interviewed Senior Researcher Rui Yin, who validated our exploration and explained the discrepancy: conventional “third layer” is often ambiguously defined, but should be split into two sub-layers. He advised investigating their specific parameters separately.

    Figure 5: Interview with Senior Researcher Yin Rui.
    9th post on REDnote
    2025.7.4

    We participated in the SUSTech-SynBio Community Exchange Meeting as special guests, sharing the experience of achieving last year’s excellent results.

    Figure 1: 9th post on REDnote.
    14th WeChat press release
    2025.7.5

    We released the 14th WeChat official account post, centering on the technology of TALENs.

    Figure 2: 14th WeChat press release.
    Teachers’ Reference Book: All-ages Synthetic Biology, Course 1-5
    2025.7.5-2025.7.29

    We designed courses 1-5 of our teaching material Teachers’ Reference Book: All-ages Synthetic Biology for teachers, which is divided into three levels: primary school, junior high school and senior high school. The content revolves around the activities: Fuzzy Sticks, Cell Kingdom on Kites, Auction of Genetic Components, Super Little Inventor, and Life Code Designer.

    Figure 3: A page from the book.
    Synthetic Biology in Seven Days-Advanced Edition - Chapter 4-6 Video
    2025.7.6-2025.7.10

    We recorded chapter 4-6 of the learning material Synthetic Biology in Seven Days-Advanced Edition, respectively focusing on experimental technology, including both basic and specific; design modeling, including foundations, theory, and practices; ethical safety, including its position,issues and guiding principles.

    Figure 4: Chapter 4 video cover.
    The framework of Education wiki page
    2025.7.8

    We established the framework of Education page, classified all educational activities and gained an overall concept.

    Figure 5: The education framework.
    Dongjian’an School Activity in Shanxi Province
    2025.7.13

    We held the "Syn-bio Snakes & Ladders and Live Lab Tour" activity in Shanxi Dongjian'an School for the third time,allowing students to easily understand synthetic biology and glimpse authentic experimental settings and expand vision beyond the classroom.

    Figure 6: Dongjian’an School Activity in Shanxi Province.
    "Auction of Genetic Components" activity
    2025.7.14

    We held the "Auction of Genetic Components" activity in Shandong Licun Middle School, using analogy to explain synthetic biology and genetic engineering principles. Also,this activity linked three nearby schools, bridging cutting-edge technology and rural education.

    Figure 7: The "Auction of Genetic Components" activity
    4th experiment of the virtual laboratory-PCR
    2025.7.16

    We completed the fourth virtual lab experiment-PCR, introducing recombinant plasmids into competent cells using heat-shock method.

    Figure 8: Virtual lab experiment-PCR
    15th WeChat press release
    2025.7.21

    We released the fifteenth WeChat official account post, paying tribute to the contributions made by female scientist Ning Yan to the world.

    Figure 9: 15th WeChat press release
    5th experiment of the virtual laboratory-Cell thawing
    2025.7.22

    We completed the fifth virtual lab experiment-cell thawing, offering experience of the complete process of thawing frozen cells.

    Figure 10: Virtual lab experiment-Cell thawing
    Synthetic Biology in Seven Days-Intermediate Edition - Chapter 1-3 Video
    2025.7.24-2025.7.29

    We recorded chapters 1-3 of the Synthetic Biology in Seven Days-Intermediate Edition, focusing on the concept of iGEM, the award criteria and case interpretation, and basic theories. The difference from the advanced version is that we adjusted the knowledge content and presentation form.

    Figure 11: Chapter 1 video cover
    6th experiment of the virtual laboratory-Cell passage
    2025.7.28

    We completed the 6th virtual lab experiment-Cell passage, introducing the procedure of cell passaging.

    Figure 12: Virtual lab experiment-Cell passage
    August
    Interview with Lawyer Junling Bai
    2025.8.1-8.20

    Recognizing the legal risks across the ABCS project’s R&D, clinical, and commercialization stages, we consulted Lawyer Bai for professional guidance. She outlined key legal considerations, including biosecurity and gene technology compliance in R&D, clinical trial approvals and device regulations in application, and IP protection and advertising laws in commercialization. Following her advice, we began strengthening our legal risk management system to ensure compliance.

    Figure 1: Interview with Lawyer Junling Bai.
    Interview with Professor Jinshan Zhang from the School of Innovation and Entrepreneurship
    2025.8.21-8.26

    To explore how to transform ABCS into a real-world startup, we interviewed Prof. Zhang, an expert in innovation and entrepreneurship. He emphasized shifting from technical to entrepreneurial thinking and introduced the "entrepreneurial capability matrix", highlighting essential areas like market awareness, fundraising, and strategic planning.

    Figure 2: Interview with Professor Jinshan Zhang.
    Obtaining the hospital ethics approval document
    2025.8.27-8.28

    We first submitted an application to the ethics committee of China-Japan Union Hospital of Jilin University. The ethics committee conducted a strict review of the application, and we finally successfully obtained the hospital's ethical review approval, laying a legal and compliant foundation for the offline interview activities.

    Figure 3: Ethics Approval Document.
    Completion of the iGEM Entrepreneurship Practice Simulation handbook
    2025.8.29-9.9

    To help our team familiarize with entrepreneurial processes and boost decision-making capabilities via collaboration, we developed our own "iGEM Entrepreneurship Practice Simulation", which will let team members grasp the full entrepreneurial process and enhance capabilities through comprehensive sandbox-based simulations.

    Figure 4: The iGEM Entrepreneurship Practice Simulation Handbook.
    Teachers’ Reference Book: All-ages Synthetic Biology, Courses 6-7
    2025.8.2

    We designed course 6-7 of Teachers’ Reference Book: All-ages Synthetic Biology for teachers. The content revolves respectively around the "Bacterial Adventure-Our Friends "Activity and popularization for autistic children.

    Figure 1: A page from the book.
    10th post on REDnote
    2025.8.3

    We participated in the iBridge Exchange Meeting, sharing the experience of achieving excellent results last year and introducing our 2025 project.

    Figure 2: 10th post on REDnote.
    Synthetic Biology in Seven Days-Intermediate Edition - Chapter 4-6 Videos
    2025.8.5-8.11

    We recorded videos explaining the 4-6 chapters of the Synthetic Biology in Seven Days-Intermediate Edition, respectively focusing on the design and analysis methods of synthetic biology, explaining practical information; the importance of modeling in the iGEM competition and its biological foundations; ethical challenges and principles.

    Figure 3: Chapter 4 video cover.
    Attending CCiC (Conference of China iGEMer Community)
    2025.8.6-2025.8.8

    We went to Beijing to attend CCiC, conducting presentations and displaying our project posters, and reached a consensus for cooperation through continuous communication with other teams. During this period, we also attended the functional nucleic acid seminar organized by PekingHSC iGEM team, and ultimately we reached a consensus to jointly produce a functional nucleic acid white paper.

    Figure 4: CCiC on-site pictures.
    1st podcast
    2025.8.9

    We released the first podcast series, discussing the fermentation function of yeast and the factors that influence its functionality.

    Figure 5: 1st podcast series.
    7th experiment of the virtual laboratory-Cell freezing
    2025.8.10

    We designed the seventh virtual lab experiment-Cell freezing, introducing the basics principles and techniques of long-term cell storage.

    Figure 6: Virtual lab experiment-Cell freezing.
    Exchange meetings with international iGEM teams
    2025.8.14-8.19

    We met online with 3 international iGEM teams-iGEM Lund, iGEM NYUAD, and iGEM McGill-during this period to exchange our projects and promote our education collaboration.

    Figure 7: Screenshots from the exchange meetings.
    16th WeChat press release
    2025.8.14

    We released the sixteenth WeChat official account post, recording the entire process we had at CCiC and sharing our gains.

    Figure 8: 16th WeChat post.
    11th post on REDnote
    2025.8.15

    We released the eleventh post on REDnote, documenting the entire process over our three days at CCiC.

    Figure 9: 11th post on REDnote.
    2nd podcast
    2025.8.15

    We released the second podcast, which tells the story of beneficial bacteria cleaning the sewers, demonstrating that bacteria can also be helpful.

    Figure 10: 2nd podcast.
    Synthetic Biology in Seven Days- Basic Edition - Chapter 1-2 Videos
    2025.8.17

    We recorded a video explaining the first chapter of the Synthetic Biology in Seven Days-Basic Edition, introducing the core concepts of the iGEM competition by using a friendly opening, strong interactivity, and a combination of rich visuals and explanations to enhance perception.

    Figure 11: Chapter 1 video cover.
    12th post on REDnote
    2025.8.20

    We released the twelfth post on REDnote, documenting the work we did at CCiC, including team communication, cooperation achievements, and so on.

    Figure 12: 12th post on REDnote.
    3rd podcast
    2025.8.20

    We released the third podcast, telling a story of lactic acid bacteria and other bacteria producing lactic acid to fend off harmful bacteria.

    Figure 13: 3rd podcast.
    4th podcast
    2025.8.22

    We released the fourth podcast, telling the story of photosynthetic bacteria converting weak light into energy and releasing oxygen through photosynthesis.

    Figure 14: 4th podcast.
    Synthetic Biology in Seven Days- Basic Edition - Chapter 3-6 Videos
    2025.8.29-9.9

    We recorded chapter 3-6 videos of the Synthetic Biology in Seven Days-Basic Edition, focusing on these topics:

  • Introducing iGEM in the form of physical analogies and simple interactive games.
  • Introducing the basic knowledge of synbio experiments in a simple pictorial way.
  • Simple hands-on biology experiments in a simulated scenario.
  • introducing the rules of experiments in iGEM and reviewing the content of the previous five chapters.
  • Figure 15: 4th podcast.
    13th post on REDnote
    2025.8.25

    We released the thirteenth post on REDnote and created a new series-knowledge cards, revolving which direction the public is most interested in understanding synthetic biology, listing 5 options, and explaining the one with the highest votes in 3 days.

    Figure 16: 13th post on REDnote.
    5th podcast series
    2025.8.25

    We released the fifth podcast series, telling the story that acteriophages recognize and eliminate viruses.

    Figure 17: 5th podcast.
    6th podcast
    2025.8.28

    We released the sixth podcast, telling the story of how root nodule bacteria convert atmospheric nitrogen into nutrients that can be absorbed by bean sprouts.

    Figure 18: 6th podcast.
    14th post on REDnote
    2025.8.28

    We released the fourteenth post on REDnote and created a new series--knowledge cards,revolving which application the public is most interested in understanding synthetic biology, listing 5 options, and explaining the one with the highest votes after 3 days.

    Figure 19: 14th post on REDnote.
    September
    Internal training using the handbook iGEM Entrepreneurship Practice Simulation
    2025.9.10-9.17

    Our team built an entrepreneurship ability matrix by using our original "iGEM Entrepreneurship Practice Simulation" handbook, preparing for future responses to actual entrepreneurship challenges.

    Figure 1: Conducting Internal Training.
    Patient feedback word cloud
    2025.9.18-9.20

    We organized the feedback collected from patient interviews into a word cloud, ranking terms by frequency to make patients’ needs, concerns, and emotions more visually accessible. This helped us quickly identify recurring themes and gain a clearer, more intuitive understanding of what patients value most.

    Figure 2: Patient Feedback Word Cloud.
    Online patient interview
    2025.9.21-9.29

    The ABCS project needs to extensively collect the preferences of breast cancer patients for three testing methods (test kits, test strips, and automatic testing toilets) to ensure that the product form meets the actual needs of patients. Since offline interviews had limited reach, we expanded the research online through the platforms "Mijian" and "Dances with Cancer", ensuring that patient voices were included in shaping our project.

    Figure 3: Online Patient Interview.
    Completion of the business plan
    2025.9.30

    The business plan helps us deeply analyze the commercial potential of the project and determine the implementation path. It served not only as a systematic framework connecting our technology to the broader business chain, but also as a key blueprint for attracting resources and guiding practical actions.

    Figure 4: The Business Plan.
    8th experiment of the virtual laboratory - CCK-8 assay
    2025.9.2

    We designed the eighth virtual lab experiment- CCK-8 assay, simulating the adding process of CCK-8 reagent and reading absorbance values.

    Figure 1: Virtual lab experiment-CCK-8 assay.
    15-17th post on REDnote
    2025.9.4

    We released our fifteenth to seventeenth REDnote posts, launching a new knowledge card series focused on community interest. The post featured a poll that offered five different iGEM "village" topics. To overcome the platform’s limitation on voting options, we released two follow-up posts on September 15th and 19th to collect votes for the remaining villages.

    Figure 2: 15-17th post on REDnote.
    Exchange meeting with iGEM Munich
    2025.9.8

    We established contact with iGEM Munich to exchange our projects and promote collaboration on education .

    Figure 3: Meeting with iGEM Munich.
    9th experiment of the virtual laboratory-Cell transfection
    2025.9.10

    We designed the ninth virtual lab experiment-Cell transfection, focusing on choosing suitable transfection reagents and plasmid DNA.

    Figure 4: Virtual lab experiment-Cell transfection.
    17th WeChat press release
    2025.9.13

    We released the seventeenth WeChat official account post, which introduced how synthetic biology uses gene-editing technology to modify biological systems, showcasing applications in areas like eco-friendly plastics and cultured meat.

    Figure 5: 17th WeChat post.
    10th experiment of the virtual laboratory - Cell infection
    2025.9.21-9.29

    We designed the tenth virtual lab experiment-Cell infection, to help learners understand virus-mediated gene expression and its applications in research.

    Figure 6: Virtual lab experiment-Cell infection.
    Lab daily Vlog on TikTok
    2025.9.28

    We posted a video on TikTok showing the daily routines of our Experiment group.

    Figure 7: The Tiktok video.
    Wiki
    December
    WIKI & Videos group member recruitment
    2024.12.4-2025.1.4

    Upon the completion of our recruitment process, we are proud to introduce our group members: Jiaqi Qu; Fuzhi Wang; Yucheng Liu; Yilong Liao.

    January
    1st Brainstorm and drafts on wiki design
    2025.1.4-2025.1.15

    Group members focused on different wiki sections according to preference and creative ideas were put forward. The initial drafts of the Team and the HP sections were prepared, while members provided comprehensive insights on web design optimization. We shared designs of visual elements for the homepage (including the Safety, Awards, and Notebook sections), a structured navigation bar and the table of contents.

    Figure 1: Screenshots of PPT from the First Group Meeting.
    2nd Brainstorm and drafts on Wiki design
    2025.1.15-2025.1.25

    The Team page design was refined through the integration of illustrated member avatars and the navigation bar. Simultaneously, the HP page layout was optimized with matching components to ensure visual consistency. We proposed the first version of our table of contents and footer, and confirmed the font design.

    Figure 2: Screenshots of PPT from the Second Group Meeting.
    February
    3rd Brainstorm and drafts on Wiki design
    2025.2.6-2025.2.13

    Group members focused on different wiki sections, refining IHP pages while ensuring design consistency. The navigation bar, table of contents, and background color were standardized. We updated the Team page layout, added our PI and Instructors’ labels, and initiated the Notebook page. The Description page incorporated a navigation bar, a table of contents, and a footer. In the mean time we progressed on the Model section. The footer design was revised, and homepage visuals, including the HP page illustration, were created.

    Figure 1: Screenshots of PPT from the Third Group Meeting.
    4th Brainstorm and drafts on Wiki design
    2025.2.14-2025.2.22

    Group members continued refining sections, enhancing visual elements, and improving functionality across the wiki page. Updates were made to the IHP and other key page banners, along with adjustments to the footer for a more cohesive presentation. The Team page visuals were refined, as we optimized the character presentation for HP, Education, and Presentation group sections. We added more details to the Notebook page structure, including the design of overview images as interactive effects and the AI model underwent further modifications. Also, refinements were made to the Description page and navigation bar, ensuring proper integration of key identifiers and our university logo.

    Figure 2: Screenshots of PPT from the forth group meeting.
    March
    A series of events between March 2nd, 2025 and March 15th, 2025
    Apricot Blossom Festival poster

    A beautifully designed event poster was brought to life by our talented wiki group.

    Figure 1: The apricot Blossom Festival poster.
    5th brainstorm and drafts on wiki design

    Based on the needs of the Education group, we developed an educational platform and optimized several webpage widgets. Collaboration with group members is still ongoing.

    Figure 2: The initial version of the educational platform.
    6th brainstorm and drafts on wiki design

    We created a draft Attribution page referring to last year's CJUH-JLU-China team information and optimized our self-designed education platform.

    Figure 3: Screenshots of PPT from the seventh group meeting.
    Preliminary design of the team logo
    2025.3.23-2025.3.30

    Based on the meaning of our project, we have preliminarily designed six versions of the team logo for selection.

    Figure 6: Six versions of the team logo.
    Seventh Brainstorm and drafts on Wiki design
    2025.3.23-2025.3.30

    We further refined the webpages we had already built, assisted the Education group in designing jigsaw puzzles and implementing the web-based virtual lab, and also held discussions with the Model group.

    Figure 7: Our new semester started at the end of February, and our
    brainstorming meetings have transitioned to offline discussions.
    Here's a photo from one of our sessions!
    April
    The final version of the team logo
    2025.4.1-2025.4.6

    After several rounds of screening, we determined the final version of the team logo.

    Figure 1: Final version of the team logo.
    Progress of the Wiki group
    2025.4.1-2025.4.6

    We have completed the operational part and animation interaction of Experiment 1 in the virtual lab, and created the video page for the educational platform.

    The design of the Aeroplane Chess cards
    2025.4.1-2025.4.6

    Our Gene Voyage is taking off! We've finished designing and illustrating our very own Aeroplane Chess cards.

    Figure 2: The design of the Aeroplane Chess cards.
    Design of the team uniform
    2025.4.1-2025.4.6

    We designed multiple team uniform concepts based on the team's color scheme, logo, and website theme. After two rounds of selection and revisions, we finalized the uniform design and began production.

    Figure 4: Final version of the team uniform.
    Design of the team flag
    2025.4.21-2025.4.30

    We designed our team flag by incorporating our team name, logo, and the official iGEM emblem.

    Figure 3: The team flag.
    May
    Drafts on Model and Engineering web page header images
          2025.5.1-2025.5.25

    We finished the drafts of Model and Engineering web page header images.

    Gene Component Auction lecture
    Figure 1: Model web page header image.
    Planting the Seeds of Synthetic Biology lecture
    Figure 2: Engineering web page header image.
    June
    Half-body portraits of the Model group members
    2025.6.1-2025.6.8

    To better showcase our team members, we began to arrange half-body portraits for our team members, starting from the Model group.

    Figure 1: Half-body portraits of the Model group members.
    Refinement of the Attributions web page header image
    2025.6.8-2025.6.30

    In order to better suit our features, Wiki members have further improved the Attributions page header image.

    Figure 4: The refined Attributions web page header image.
    July
    CCiC (Conference of China iGEMer Community) poster design
    2025.7.1-2025.7.8

    The annual event CCiC is a great chance to exchange with national iGEM teams and gain inspiration for improving our own work. We designed a poster for the conference and planned to share our design ideas with other iGEM teams.

    Figure 1: CCIC poster design.
    Logo for the ethical risk assessment model "BEAM"
    2025.7.9-2025.7.13

    Based on the meaning of "BEAM", the image of a lighthouse came to our mind. Therefore, the logo features a lighthouse as its main element, radiating light in all directions. Since "beam" is an ethical model, the little figures holding hands symbolize its people-centered philosophy.

    Figure 2: Logo for BEAM.
    Completion of the Contribution wiki page cover image
    2025.7.14-2025.7.20

    Regarding the meaning of the "contribution" page in iGEM, we started with the Earth as the basic image, then expanded the idea to include tides and the universe. This process eventually led to the final version of the full image.

    Figure 3: The Contribution wiki page cover image.
    The creation of 4 cover images for the front pages
    2025.7.14-2025.7.20

    Based on the main ideas represented by different pages, we created the drawing for the iHP, Model, Engineering, and Collaboration page.

    Figure 4: Drafts of the 4 cover images.
    Completion of 4 cover images
    2025.7.14-2025.7.20

    Based on the main themes, we designed the illustration for the Design, Protocol, Parts, and Results page.

    Figure 5: Drafts of the 4 cover images.
    August
    Virtual Laboratory page design
    2025.8.1-2025.8.10

    In order to make the virtual laboratory pages look more attractive, their layouts have been redesigned.

    Figure 1: New Virtual Laboratory page design.
    Mechanism animation graphic design
    2025.8.11-2025.8.17

    To enhance the clarity and appeal of our project mechanism in the promotion video, we designed a series of custom graphics to visually explain the core science.

    Figure 2: Graphics for the promotion video.
    Completed the cover image of the "Description", "Education" page
          2025.8.18-2025.8.24

    We improved the "Description", "Education" cover image.

    Gene Component Auction lecture
    Figure 3: Cover image of the "Description" page.
    Planting the Seeds of Synthetic Biology lecture
    Figure 4: Cover image of the "Education" page.
    We moved the Description page from local hosting to the official iGEM website
    2025.8.18-2025.8.23

    On August 18, 2025, we deployed the Description page to our locally hosted site. After five days of revisions and polishing, on August 23, 2025, we officially published it on the iGEM website.

    Completed the cover image of the "Safety" page
    2025.8.25-2025.8.31

    Integrating the shield and the spear, which symbolize protection, we completed the cover image of "Safety".

    Figure 5: Cover image of the "Safety" page.
    September
    Completion of the Model page cover image
    2025.9.1-2025.9.7

    Based on the elements of our two models, we designed the cover image of Model page.

    Figure 1: Cover image of the Model page.
    Completion of the Software page cover image
    2025.9.1-2025.9.7

    Integrating the unique technological elements of the software, the cover image of the software was designed.

    Figure 2: Cover image of the Software page.
    Completion of the Design page cover image
    2025.9.8-2025.9.14

    In response to the requirements for beautification in the promotion video, some graphic refinement has been carried out.

    Figure 3: The Design page cover image.
    Completion of the iHP page cover image
    2025.9.8-2025.9.14

    The cover image of iHP website was designed to convey a sense of connecting to the world.

    Figure 4: Cover image of the iHP page.
    Completion of the Engineering page cover image
    2025.9.8-2025.9.14

    We carefully designed and developed the final page drawing on the scenarios we envisioned and our understanding of the Engineering page.

    Figure 5: Cover image of the Engineering page.
    Completion of the cover image for the art page
    2025.9.15-2025.9.21

    Drawing on the scenarios we envisioned and our understanding of the Art page, we carefully designed and developed the final Art page.

    Figure 6: Cover image of the Art page.
    Completion of the Results page cover image
    2025.9.15-2025.9.21

    Based on the connection with "results", the image of wheat ears was added, aiming to convey the idea of achieving a harvest.

    Figure 7: Cover image of the Results page.
    Home Page Design
    2025.9.15-2025.9.21

    The homepage hero image was created by integrating our project theme and the main character design.

    Figure 8: Home Page Design.
    Completion of the Virtual Laboratory
    2025.9.21

    After more than half a year of dedicated effort, our Wiki team and HP & Education team have successfully completed the Virtual Laboratory. It contains ten biology experiments and represents a great deal of hard work. A detailed introduction is provided on our Wiki.

    Completion of the Medal page cover image
    2025.9.22-2025.9.31

    Based on the association with medal, we aimed to convey a golden and radiant visual aesthetic for the cover image.

    Figure 9: Cover image of the Medal page.
    Design of the Loading Animation
    2025.9.22-2025.9.31

    Based on our unique web style, we designed a distinctive loading page.

    Figure 10: Design of the Loading Animation.
    Home Subpage in Picture Book Style
    2025.9.22-2025.9.31

    Aiming for a unique home subpage design, we eventually selected a picture book style rich in texture.

    Figure 11: Home Subpage in Picture Book Style.
    Presentation
    December
    Presentation Group Member Recruitment
    2024.12.14-2024.12.22

    Through team recruitment, our presentation group was set up by 4 outstanding undergraduate students from Jilin University, Sirui Dong, Changning Fu and Hongrui Yu from the first clinical school and Zimu Li from the School of Chemistry.

    January
    Preliminary Brainstorm of Promotion Video
    2024.12.14-2025.01.20

    During the initial phase of the Presentation group's activities, we prepared the Material Library of project’s promotion video to make members be more familiar with iGEM project and presentation work. Through brainstorming, discussions and learning promotion video of past gold projects, we finally came up with 3 different design of promotion video.

    Figure 1: Screenshot of the PPT for the Promotion Video
    Online Group Meeting.
    Design of Attribution page
    2025.1.20-2025.1.27

    According to the review of judges in 2024 jamboree, some problems were pointed out in our attribution page that we need to solve this year. Therefore, we decided to consider our attribution page earlier to avoid the mistakes. After case studies of outstanding projects, we designed the components and texts of this year’s attribution page.

    February
    Design and Development of Notebook Page
    2025.01.20-2025.02.22

    In our review of 2024 jamboree, our notebook had problems in page loading and readability. Therefore, we start planning our notebook at the begin of this year’s project. We conducted case studies of top teams JU-Krakow and Heidelberg, making grate updates in way of presenting our notebook. After design is decided, we made demo web page with the help of wiki group.

    Figure 1: Screenshot of the PPT for the Notebook
    Online Group Meeting.
    March
    Event: Drafting of questions in Web Helper
    2025.03.09-2025.03.16

    The idea of creating an online web helper in our wiki came up by our wiki group members. Inspired by websites that built-in chatbots or virtual assistants, we recognized that we could develop our own chatbots in our wiki to answer questions relative to our project that viewers of our wiki may ask. Therefore, our project can be interpreted better and help iGEMers locating what they are curious about more quickly. We brainstormed some questions people may ask and collect them down. We will continue collecting questions and answer them while the project develops gradually.

    Figure 1: Questions for the Web Helper.
    Preliminary Design and Drafting of Safety Page
    2025.03.23-2025.04.05

    The safety page was one of the weak points in our wiki last year. In the past, we considered safety to be a limited concept that only involved wet lab safety. However, after viewing other teams’ wiki, we have realized that safety is a multifaceted concept, which not only about laboratory safety but also biosafety of projects and the social and psychological safety in HP activities etc. For this reason, we started preparing the safety page in advance, redesigning its content outline and developing the page layout.

    Figure 2: Screenshot of the PPT for the Safety Page
    Online Group Meeting.
    Preliminary Preparation of Presentation video
    2025.02.26-2025.03.09

    We prepared the Material Library of project’s presentation video early this year to ensure our video attractive and suitable to project. Through brainstorming, discussions and learning presentation video of past iGEM projects, we finally came up with 3 different designs of presentation video.

    Illustration of Project Mechanism Flowchart
    2025.03.23-2025.04.20

    We created the project mechanism flowchart with the help of BioRender. With the help of the experiment group, we drafted the initial chart and improved it through wide discussion. After 2 times of completely revised and redrawn, we illustrated the first version of project mechanism flowchart.

    Figure 3: The Iterative Process of Illustrating the
    Project Mechanism Flowchart.
    April
    Launch of Safety page
    2025.04.05-2025.04.20

    After a month of dedicated effort, we completed the drafting and refinement of the safety documentation. We also visited the laboratory to photograph and organize visual materials of the safety equipment. With the support of the Wiki group, we finalized a local demo version of the Safety webpage.

    Figure 1: Photos collected for Safety page.
    Refinement of project mechanism flowchart
    2025.04.20-2025.05.18

    We update the project mechanism flowchart with the help of BioRender. We revisited and restructured the modeling of tumor cell–adipocyte interactions, with a particular focus on detailing the cytokine-mediated pathways affecting adipocytes, to enhance the clarity and communicability of our project’s underlying mechanism.

    Figure 2: Updated project mechanism flowchart
    May
    Preliminary design of the promotion video
    2025.04.28-2025.05.18

    We have started designing the promotion video and completed the first draft of the script, along with a preliminary plan for the visual style and content. After discussions with Experiment group, the script was refined and some inaccuracies in the part mentioning the project’s theoretical foundation were corrected.

    Figure 1:Part of our initial design.
    Drafting the Description section
    2025.05.06-2025.05.18

    We developed an outline and accordingly finished the first draft of the Description section.

    Figure 2:The initial outline of Description.
    Description restructuring and content revision
    2025.05.18-2025.06.05

    Our first draft felt too rigid, so we revised the content based on a restructured framework, resulting in a more reader-friendly Description section.

    Figure 3: The restructured Description framework.
    July
    Filming the promotion video
    2025.7.10- 2025.8.1

    We began filming the footage of our promotion video. Unlike last year’s animation, this year we adopted live-action shooting, and involved many of our team members in the filming process.

    Figure 1: CCIC poster design
    August
    Editing the promotion video
    2025.8.1-8.12

    After filming the footage in July, we edited and uploaded this year’s promotion video.

    Figure 1: Cover of the promotion video.
    Description page writing
    2025.8

    started writing the Description page. This page presents the core objectives, technical road map, and scientific significance of the experiment to the entire project.

    Education page writing
    2025.8

    This month we co-created the Education page with the Education group, revised the text and translated it into English.

    Improving the Team page
    2025.8

    In the writing of the iGEM Team page, we clearly presented the interdisciplinary architecture of the team, introduced the modules they were responsible for, such as experimental operations, data simulation, and promotional design, and deeply linked the team roles with project goals, refining their work content.

    September
    Human Practices page writing
    2025.9

    This month we co-created the Human Practices page with the HP group, revised the text and translated it into English.

    Presentation video design and script writing
    2025.9

    We started planning our presentation video, and finished the draft of our script along with initial visual design.

    Manuscript writing and revision of Model Page
    2025.9

    We finished writing the Model wiki content. By communicating with members of the Model group, we gained a good understanding of the models, and then revised and polished the manuscript and the wiki page’s image layout.